AMPK, Mitochondrial Function, and Cardiovascular Disease
Open accessAbstract
Adenosine monophosphate-activated protein kinase (AMPK) is in charge of numerous catabolic and anabolic signaling pathways to sustain appropriate intracellular adenosine triphosphate levels in response to energetic and/or cellular stress. In addition to its conventional roles as an intracellular energy switch or fuel gauge, emerging research has shown that AMPK is also a redox sensor and modulator, playing pivotal roles in maintaining cardiovascular processes and inhibiting disease progression. Pharmacological reagents, including statins, metformin, berberine, polyphenol, and resveratrol, all of which are widely used therapeutics for cardiovascular disorders, appear to deliver their protective/therapeutic effects partially via AMPK signaling modulation. The functions of AMPK during health and disease are far from clear. Accumulating studies have demonstrated crosstalk between AMPK and mitochondria, such as AMPK regulation of mitochondrial homeostasis and mitochondrial dysfunction causing abnormal AMPK activity. In this review, we begin with the description of AMPK structure and regulation, and then focus on the recent advances toward understanding how mitochondrial dysfunction controls AMPK and how AMPK, as a central mediator of the cellular response to energetic stress, maintains mitochondrial homeostasis. Finally, we systemically review how dysfunctional AMPK contributes to the initiation and progression of cardiovascular diseases via the impact on mitochondrial function.
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that AMPK is both a redox sensor/modulator and a central regulator of mitochondrial homeostasis, with bidirectional crosstalk: mitochondrial dysfunction can alter AMPK activity, while AMPK controls mitochondrial biogenesis, dynamics, mitophagy, and Ca²⁺ handling. Dysregulated AMPK–mitochondria signaling contributes to cardiovascular disease, and drugs such as metformin, berberine, statins, polyphenols, and resveratrol may act partly through AMPK.
Key findings
- AMPK is a heterotrimeric complex of α, β, and γ subunits; all isoform combinations produce 12 different AMPK complexes. It is activated by AMP/ADP and inhibited by ATP, with LKB1 and CAMKK2 as major upstream kinases; Thr172 phosphorylation increases AMPK activity about 100-fold, while allosteric regulation changes activity up to tenfold in mammalian cells and about twofold in recombinant bacterially produced AMPK.
- AMPK functions as a redox sensor and antioxidant modulator: ROS/RNS can activate AMPK via energy stress and/or LKB1–CaMKK signaling, while activated AMPK suppresses mitochondrial and NOX-derived ROS and upregulates antioxidant genes including CAT, SOD1, SOD2, and UCP2, often through PGC1α.
- AMPK regulates mitochondrial homeostasis by promoting mitochondrial biogenesis via PGC1α, controlling mitochondrial dynamics through MFF phosphorylation at Ser155/Ser173 and DRP1, regulating mitophagy through ULK1 and PINK1–PARKIN signaling, and modulating mitochondrial Ca²⁺ influx through MCU.
- In cardiovascular disease, AMPK is generally protective across atherosclerosis, ischemia, ischemia/reperfusion injury, vascular calcification, neointimal hyperplasia, cardiac hypertrophy, diabetes, inflammation, and obesity; the review notes that reperfusion failure occurs in approximately 30% of patients with acute myocardial infarction and that ischemic heart disease accounted for 15.96% of total global deaths in 2017.
Methods
- Not stated in the paper; the text is a narrative review that synthesizes cited literature rather than presenting original experimental data.
- The review covers AMPK structure and regulation, redox regulation of AMPK, mitochondrial control of AMPK, AMPK regulation of mitochondrial homeostasis, and AMPK–mitochondria signaling in cardiovascular and cardio-metabolic diseases.
- Main analysis is qualitative synthesis of mechanistic studies across cell, animal, and some human contexts; no systematic search strategy, inclusion criteria, or meta-analysis is described.
Limitations
- Stated: the authors note that the functions of AMPK during health and disease are “far from clear” and that the interplay within the AMPK–mitochondrial axis during cardiovascular disease initiation and progression is poorly investigated.
- Stated: limited evidence has focused on mitochondrial dynamics, mitochondrial biogenesis, and mitophagy, and the structural and functional changes to mitochondria under disease conditions remain “far beyond our current knowledge.”
- Evident from the text: as a narrative review, it does not provide primary data, systematic evidence grading, or quantitative synthesis; many mechanistic conclusions are drawn from preclinical cell and animal models, with clinical evidence cited more selectively.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 250 cited sources checked · 0 supported · 0 flagged
- Interpretationnone given
Pharmacological reagents including statins, metformin, berberine, polyphenol, and resveratrol appear to deliver their protective/therapeutic effects partially via AMPK signaling modulation.
“Pharmacological reagents, including statins, metformin, berberine, polyphenol, and resveratrol, all of which are widely used therapeutics for cardiovascular disorders, appear to deliver their protective/therapeutic effects partially via AMPK signaling modulation.”
Quote in the paperNot a substantial claim - Premisecitation
Binding of AMP, and to a lesser degree ADP, to the γ-subunit stimulates AMPK activity via three mechanisms.
“Binding of AMP, and to a lesser degree ADP, to the γ-subunit stimulates AMPK activity via three mechanisms [27,28,29].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [27] Hardie, 2011, AMP-activated protein kinase: Also regulated by ADP?, Trends Biochem. Sci. source
Not checked in the free run.
- cites [28] Gowans, 2013, AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation, Cell Metab. source
Not checked in the free run.
- cites [29] Ross, 2016, Differential regulation by AMP and ADP of AMPK complexes containing different gamma subunit isoforms, Biochem. J. source
Not checked in the free run.
- Premisecitation
AMP protects Thr172 against dephosphorylation by phosphatases.
“Second, AMP protects Thr172 against dephosphorylation by phosphatases [28,35,36,37].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [28] Gowans, 2013, AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation, Cell Metab. source
Not checked in the free run.
- cites [35] Xiao, 2011, Structure of mammalian AMPK and its regulation by ADP, Nature source
Not checked in the free run.
- cites [36] Neumann, 2010, The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells, FASEB J.
Not checked in the free run.
- cites [37] Joseph, 2015, Inhibition of AMP kinase by the protein phosphatase 2a heterotrimer, PP2APpp2r2d, J. Biol. Chem. source
Not checked in the free run.
- Premisecitation
Once activated, AMPK redirects metabolism toward increased catabolism or decreased anabolism through phosphorylation of key proteins across multiple pathways, including protein synthesis, lipid homeostasis, glucose metabolism, and mitochondrial homeostasis.
“Once activated, AMPK redirects metabolism toward increased catabolism or decreased anabolism through the phosphorylation of key proteins across multiple pathways, including protein synthesis (e.g., mammalian target of rapamycin complex (1) [2,3], lipid homeostasis (e.g., acetyl coenzyme A carboxylase, ACC) [4,5], glucose metabolism (e.g., phosphofructokinase (2) [6], and mitochondrial homeostasis”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [2] Gwinn, 2008, AMPK phosphorylation of raptor mediates a metabolic checkpoint, Mol. Cell source
Not checked in the free run.
- cites [3] Inoki, 2003, TSC2 mediates cellular energy response to control cell growth and survival, Cell source
Not checked in the free run.
- cites [4] Carling, 1987, A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis, FEBS Lett. source
Not checked in the free run.
- cites [5] Munday, 1988, Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase, Eur. J. Biochem. source
Not checked in the free run.
- cites [7] Jager, 2007, AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- Premisenone given
AMPK is activated by energy stress and/or cellular stress in response to increased ATP consumption or decreased ATP production, sensed as low ratios of ATP-to-AMP/ADP.
“AMPK is activated by energy stress and/or cellular stress in response to increased ATP consumption (e.g., exercise, cell proliferation, and anabolism) or decreased ATP production (e.g., low glucose levels, oxidative stress, and hypoxia), which are sensed as low ratios of ATP-to-AMP/ADP.”
Quote in the paperSubstantial claim
- Interpretationreasoning
Activated AMPK balances energy levels by raising ATP synthesis and/or reducing ATP consumption.
“Overall, activated AMPK balances energy levels by raising ATP synthesis and/or reducing ATP consumption.”
Quote in the paperNot a substantial claim - Premisenone given
AMP causes allosteric activation of AMPK that has already been phosphorylated on Thr172.
“Third, AMP causes the allosteric activation of AMPK that has already been phosphorylated on Thr172.”
Quote in the paperNot a substantial claim - Premisecitation
AMPK activates upon binding with AMP or ADP under conditions of insufficient energy.
“Under conditions of insufficient energy, AMPK activates upon its binding with AMP or adenosine diphosphate (ADP) [1].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Hardie, 2012, AMPK: A nutrient and energy sensor that maintains energy homeostasis, Nat. Rev. Mol. Cell Biol. source
Not checked in the free run.
- Premisecitation
Exposure of exogenous hydrogen peroxide to C2C12 cells led to a dose-dependent increase in AMPK activity by decreasing the ATP-to-ADP ratio.
“For instance, exposure of exogenous hydrogen peroxide to C2C12 cells led to a dose-dependent increase in AMPK activity by decreasing the ATP-to-ADP ratio [44].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Hinchy, 2018, Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly, J. Biol. Chem. source
Not checked in the free run.
- Premisecitation
The protective effects of fucoxanthin were attributed to activation of the AMPK-protein kinase C-NOX signaling pathway.
“The protective effects of fucoxanthin were attributed to activation of the AMPK-protein kinase C-NOX signaling pathway.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] Ou, 2019, Fucoxanthin protects against oxLDL-induced endothelial damage via activating the AMPK-Akt-CREB-PGC1alpha pathway, Mol. Nutr. Food Res. source
Not checked in the free run.
- Premisecitation
Decreased NO bioavailability, manifested as impaired vasodilation, represents one of the early signs of atherosclerosis.
“Decreased NO bioavailability, manifested as impaired vasodilation, represents one of the early signs of atherosclerosis [154].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [154] Davignon, 2004, Role of endothelial dysfunction in atherosclerosis, Circulation source
Not checked in the free run.
- Premisecitation
The main mechanism of salidroside relied on stimulation of eNOS activation and NO production through AMPK-dependent activation of the phosphatidylinositol-3-kinase-protein kinase B pathway.
“The main mechanism relied on the stimulation of eNOS activation and NO production through the AMPK-dependent activation of the phosphatidylinositol-3-kinase- protein kinase B pathway [130].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [130] Xing, 2015, Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway, Vascul. Pharmacol. source
Not checked in the free run.
- Premisecitation
Dominant negative mutation of LKB1 abolished both TPr agonist and hydrogen peroxide-stimulated AMPK activation, suggesting that hydrogen peroxide mediated TPr-triggered AMPK activation by LKB1 signaling.
“Further, dominant negative mutation of LKB1 abolished both TPr agonists and hydrogen peroxide-stimulated AMPK activation, which suggested that hydrogen peroxide mediated TPr-triggered AMPK activation by LKB1 signaling [61].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] Zhang, 2008, Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide, Circ. Res. source
Not checked in the free run.
- Premisecitation
Fucoxanthin alleviated oxidative damage of endothelial cells treated by oxLDL.
“Fucoxanthin, a natural marine carotenoid extracted from edible seaweeds, alleviated oxidative damage of ECs treated by oxLDL.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [129] Ou, 2019, Fucoxanthin protects against oxLDL-induced endothelial damage via activating the AMPK-Akt-CREB-PGC1alpha pathway, Mol. Nutr. Food Res. source
Not checked in the free run.
- Premisecitation
In HEK293 cells expressing AMPKγ2 R531G, an AMP-insensitive AMPK complex, AMPK cannot be activated by hydrogen peroxide.
“Further, using HEK293 cells expressing AMPKγ2 R531G, an AMP-insensitive AMPK complex, AMPK cannot be activated by hydrogen peroxide [46].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Hawley, 2010, Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation, Cell Metab. source
Not checked in the free run.
- Premisecitation
AMPK is activated by hydrogen peroxide in various cell types.
“AMPK is activated by hydrogen peroxide in various cell types.”
Quote in the paperNot a substantial claim - Premisecitation
Exposure of cultured rat VSMCs to either TPr agonists or hydrogen peroxide led to AMPK activation in a time- and dose-dependent manner, supported by increased phosphor-AMPK at Thr172 and phosphor-ACC at Ser79.
“Exposure of cultured rat VSMCs to either TPr agonists or hydrogen peroxide led to AMPK activation in a time- and dose-dependent manner, as supported by the increased phosphor-AMPK at Thr172 and its downstream enzyme phosphor-ACC at Ser79 [61].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Zhang, 2008, Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide, Circ. Res. source
Not checked in the free run.
- Premisecitation
AMPK lies upstream of the phosphatidylinositol-3-kinase-protein kinase B pathway, which also leads to eNOS activation and NO production.
“Further evidence also shows that AMPK lies upstream of the phosphatidylinositol-3-kinase-protein kinase B pathway, which also leads to eNOS activation and NO production [162,164,165].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [162] Levine, 2007, Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK -> Rac1 -> Akt -> endothelial nitric-oxide synthase pathway, J. Biol. Chem. source
Not checked in the free run.
- cites [164] Ouchi, 2004, Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells, J. Biol. Chem. source
Not checked in the free run.
- cites [165] Nagata, 2003, AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress, J. Biol. Chem. source
Not checked in the free run.
- Premisecitation
ROS in excess can provoke energy stress and metabolic failure by directly oxidizing and inactivating enzymes of the tricarboxylic acid cycle, electron transport chain, and glycolysis.
“ROS, in excess, can provoke energy stress and metabolic failure by direct oxidizing and inactivating enzymes of the tricarboxylic acid cycle, electron transport chain (ETC), and glycolysis [62,63].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
AMPK acts as a direct activator of eNOS by phosphorylating its Ser1177 residue.
“AMPK is activated and in turn acts as a direct activator of eNOS by phosphorylating its Ser1177 residue [163].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [163] Chen, 2009, AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633, Circ. Res. source
Not checked in the free run.
- Premisecitation
Salidroside-induced AMPK activation was presumably related to moderate depolarization of ΔΨm and subsequent increase of the cytosolic AMP-to-ATP ratio.
“Salidroside-induced AMPK activation was presumably related to the moderate depolarization of ΔΨm and subsequent increase of the cytosolic AMP-to-ATP ratio [130].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [130] Xing, 2015, Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway, Vascul. Pharmacol. source
Not checked in the free run.
- Interpretationreasoning
The target for hydrogen peroxide may not be AMPK itself, but components of the electron transport chain, leading to a secondary effect on AMPK through changes to ADP, AMP, and ATP.
“These findings suggest that the target for hydrogen peroxide may not be AMPK itself, but components of the ETC, leading to a secondary effect on AMPK through changes to ADP, AMP, and ATP.”
Quote in the paperNot a substantial claim - Premisecitation
Addition of Trolox to mouse embryonic fibroblasts resulted in basal AMPK activity reduction, evidenced by decreased phosphor-AMPKα at Thr172.
“The addition of Trolox to mouse embryonic fibroblasts (MEFs) resulted in basal AMPK activity reduction, as evidenced by the decreased phosphor-AMPKα at Thr172 [51].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Rabinovitch, 2017, AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species, Cell Rep. source
Not checked in the free run.
- Premisecitation
Salidroside efficiently decreased atherosclerotic plaque formation in LDL receptor-deficient mice.
“Salidroside, a phenylpropanoid glycoside isolated from the medicinal plant Rhodiola rosea, efficiently decreased atherosclerotic plaque formation in LDL receptor-deficient mice [130].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [130] Xing, 2015, Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway, Vascul. Pharmacol. source
Not checked in the free run.
- Premisecitation
AMPK is responsive to imbalanced redox status.
“Recent lines of evidence have demonstrated AMPK responsiveness to imbalanced redox status, thus bringing new insights into the networks of redox-stimulated signals upstream of AMPK (Table 1) [42,43,44,45,46,47,48,49,50,51].”
Quote in the paperSubstantial claim0 of 10 sources checked- cites [42] Liangpunsakul, 2008, Effect of ethanol on hydrogen peroxide-induced AMPK phosphorylation, Am. J. Physiol. Gastrointest. Liver Physiol. source
Not checked in the free run.
- cites [43] Han, Y., Wang, Q., Song, P., Zhu, Y., and Zou, M.H. (2010). Redox regulation of the AMP-activated protein kinase. PLoS ONE, 5. source
Not checked in the free run.
- cites [44] Hinchy, 2018, Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly, J. Biol. Chem. source
Not checked in the free run.
- cites [45] Choi, 2001, The regulation of AMP-activated protein kinase by H(2)O(2), Biochem. Biophys. Res. Commun. source
Not checked in the free run.
- cites [46] Hawley, 2010, Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation, Cell Metab. source
Not checked in the free run.
- cites [47] McCullough, 2005, Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke, J. Biol. Chem. source
Not checked in the free run.
- cites [48] Zmijewski, 2010, Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase, J. Biol. Chem. source
Not checked in the free run.
- cites [49] Xie, 2006, Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells, J. Biol. Chem. source
Not checked in the free run.
- cites [50] Wu, 2015, Activation of AMPKalpha2 in adipocytes is essential for nicotine-induced insulin resistance in vivo, Nat. Med. source
Not checked in the free run.
- cites [51] Rabinovitch, 2017, AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species, Cell Rep. source
Not checked in the free run.
- Premisecitation
Obesity, diabetes mellitus, smoking, chronic kidney disease, and so on participate in the pathogenesis of atherosclerosis via a mechanism of changing NO bioavailability.
“Obesity, diabetes mellitus, smoking, chronic kidney disease, and so on participate in the pathogenesis of atherosclerosis via a mechanism of changing NO bioavailability [153].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [153] Chen, 2018, Nitric oxide bioavailability dysfunction involves in atherosclerosis, Biomed. Pharmacother. source
Not checked in the free run.
- Premisecitation
Esculetin has been reported to protect HUVEC against cytotoxicity after exposure of linoleic acid hydroperoxide, likely via its radical scavenging ability.
“Esculetin has been reported to protect HUVEC against cytotoxicity after exposure of linoleic acid hydroperoxide, which is likely via its radical scavenging ability [166].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [166] Kaneko, 2001, Structure-activity relationship of antioxidants for inhibitors of linoleic acid hydroperoxide-induced toxicity in cultured human umbilical vein endothelial cells, Cytotechnology source
Not checked in the free run.
- Interpretationreasoning
AMPK activation by hydrogen peroxide occurs through activation of either LKB1 or CaMKK, depending on the cell type.
“These results collectively suggest that AMPK activation by hydrogen peroxide occurs through activation of either LKB1 or CaMKK, depending on the cell type.”
Quote in the paperNot a substantial claim - Interpretationcitation
AMPK is essential in maintaining NO bioavailability.
“Increasing evidence suggests that AMPK is essential in maintaining NO bioavailability.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [163] Chen, 2009, AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633, Circ. Res. source
Not checked in the free run.
- Premisecitation
Carvedilol modulates cardiac AMPK signaling to reduce ischemic insults by I/R.
“Carvedilol modulates cardiac AMPK signaling to reduce ischemic insults by I/R [182].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [182] Hu, 2019, The cardioprotective effects of carvedilol on ischemia and reperfusion injury by AMPK signaling pathway, Biomed. Pharmacother. source
Not checked in the free run.
- Premisecitation
Anti-atherogenic effects of mitochondria-targeted esculetin are likely owing to promotion of mitochondrial biogenesis through AMPK-SIRT3 signaling.
“Notably, the anti-atherogenic effects of mitochondria-targeted esculetin are likely owing to the promotion of mitochondrial biogenesis through AMPK–SIRT3 signaling [131].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [131] Karnewar, 2016, Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: Potential implications in atherosclerosis, Sci. Rep. source
Not checked in the free run.
- Premisecitation
In cultured human aortic endothelial cells, mitochondria-targeted esculetin significantly inhibited angiotensin II-induced cell death via enhancement of NO production via AMPK-eNOS signaling.
“In cultured human aortic endothelial cells, mechanistic study showed that mitochondria-targeted esculetin significantly inhibited angiotensin II-induced cell death via enhancement of NO production via AMPK–eNOS signaling [131].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [131] Karnewar, 2016, Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: Potential implications in atherosclerosis, Sci. Rep. source
Not checked in the free run.
- Premisecitation
Impairment of tube formation in AMPKα1−/− or AMPKα2−/− cells could be normalized by adenoviral overexpression of UCP2.
“Further, the impairment of tube formation in AMPKα1−/− or AMPKα2−/− cells could be normalized by adenoviral overexpression of UCP2 [132].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Xu, 2011, Impaired expression of uncoupling protein 2 causes defective postischemic angiogenesis in mice deficient in AMP-activated protein kinase alpha subunits, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- Premisecitation
AMPK activation shows a protective effect on cardiomyocytes under myocardial ischemic injury.
“A growing body of evidence has indicated that AMPK activation shows a protective effect on cardiomyocytes under myocardial ischemic injury [170].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [170] Young, 2008, AMP-activated protein kinase conducts the ischemic stress response orchestra, Circulation source
Not checked in the free run.
- Interpretationcitation
Cardioprotective effects of metformin on I/R are mediated by its activation of AMPK.
“Recent studies suggest that the cardioprotective effects of metformin on I/R are mediated by its activation of AMPK.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [183] Calvert, 2008, Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling, Diabetes source
Not checked in the free run.
- Interpretationcitation
Myocardial AMPK-eNOS activation by metformin following I/R led to cardioprotection.
“These findings provide important information that myocardial AMPK–eNOS activation by metformin following I/R led to cardioprotection [183].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [183] Calvert, 2008, Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling, Diabetes source
Not checked in the free run.
- Premisecitation
AMPK activation plays a crucial role in mitochondrial quality control under chronic hypoxia via modulating mitophagy in the heart.
“AMPK activation plays a crucial role in mitochondrial quality control under chronic hypoxia via modulating mitophagy in the heart [133].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [133] Zhang, 2018, AMPK activation serves a critical role in mitochondria quality control via modulating mitophagy in the heart under chronic hypoxia, Int. J. Mol. Med.
Not checked in the free run.
- Premisecitation
I/R injury is primarily induced by endothelial cell apoptosis in microcirculation.
“I/R injury is primarily induced by endothelial cell apoptosis in microcirculation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [179] Kloner, 1974, The “no-reflow” phenomenon after temporary coronary occlusion in the dog, J. Clin. Investig. source
Not checked in the free run.
- Premisecitation
Inhibition of AMPK by either pharmacological inhibitor compound C or gene silencing significantly reduced tube formation in HUVECs.
“Study showed that inhibition of AMPK by either pharmacological inhibitor compound C or gene silencing significantly reduced tube formation in HUVECs [132].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Xu, 2011, Impaired expression of uncoupling protein 2 causes defective postischemic angiogenesis in mice deficient in AMP-activated protein kinase alpha subunits, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- Premisecitation
Administration of NO donor sodium nitroprusside restored tube formation in both AMPKα1−/− and AMPKα2−/− mice.
“Alternatively, administration of NO donor, sodium nitroprusside, restored the tube formation in both AMPKα1−/− and AMPKα2−/− mice [132].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Xu, 2011, Impaired expression of uncoupling protein 2 causes defective postischemic angiogenesis in mice deficient in AMP-activated protein kinase alpha subunits, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- Premisecitation
Carvedilol treatment improved calcium homeostasis with rescuing the peak Ca2+ signal, the maximum rate of Ca2+ change during contraction and relaxation under hypoxia conditions.
“Importantly, carvedilol treatment improved calcium homeostasis with rescuing the peak Ca2+ signal, the maximum rate of Ca2+ change during contraction and relaxation under hypoxia conditions [182].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [182] Hu, 2019, The cardioprotective effects of carvedilol on ischemia and reperfusion injury by AMPK signaling pathway, Biomed. Pharmacother. source
Not checked in the free run.
- Premisecitation
Reperfusion failure occurs in approximately 30% of patients with acute MI despite successful revascularization.
“Despite the successful revascularization of occluded vessels in the heart, reperfusion failure occurs in approximately 30% of patients with acute MI [177,178].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [177] Dauber, 1990, Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion, Circ. Res. source
Not checked in the free run.
- cites [178] Weir, 2010, Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction, Circ. Cardiovasc. Imaging source
Not checked in the free run.
- Premisecitation
Hypoxia activates AMPK through the ROS-mediated opening of calcium release-activated calcium channels.
“Hypoxia activates AMPK through the ROS-mediated opening of calcium release-activated calcium channels [58,133].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [58] Mungai, 2011, Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels, Mol. Cell. Biol. source
Not checked in the free run.
- cites [133] Zhang, 2018, AMPK activation serves a critical role in mitochondria quality control via modulating mitophagy in the heart under chronic hypoxia, Int. J. Mol. Med.
Not checked in the free run.
- Premisecitation
Excessive mitochondrial fission aggravates cardiac I/R injury via alternating the balance of pro- and anti-survival factors.
“Excessive mitochondrial fission aggravates cardiac I/R injury via alternating the balance of pro- and anti-survival factors [184].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [184] Ji, 2016, Aldehyde dehydrogenase 2 has cardioprotective effects on myocardial ischaemia/reperfusion injury via suppressing mitophagy, Front. Pharmacol. source
Not checked in the free run.
- Premisecitation
Mitochondrial homeostasis is a critical regulator of cell death during cardiac I/R injury, especially mitochondrial fission and mitophagy.
“Recently, mitochondrial homeostasis has been attributed as a critical regulator of cell death during cardiac I/R injury, especially mitochondrial fission and mitophagy [184].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [184] Ji, 2016, Aldehyde dehydrogenase 2 has cardioprotective effects on myocardial ischaemia/reperfusion injury via suppressing mitophagy, Front. Pharmacol. source
Not checked in the free run.
- Premisecitation
Beneficial actions of metformin disappeared in cardiac-specific dominant-negative AMPKα2 transgenic mice or eNOS deficient mice.
“The beneficial actions of metformin disappeared in cardiac-specific dominant-negative AMPKα2 transgenic mice or eNOS deficient mice [183].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [183] Calvert, 2008, Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling, Diabetes source
Not checked in the free run.
- Premisecitation
Ischemia-induced ser1177 phosphorylation of eNOS in thigh adductor muscles was blocked in both AMPKα1−/− and AMPKα2−/− mice.
“In comparison with WT mice, the ischemia-induced ser1177 phosphorylation of eNOS in thigh adductor muscles was blocked in both AMPKα1−/− and AMPKα2−/− mice [132].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Xu, 2011, Impaired expression of uncoupling protein 2 causes defective postischemic angiogenesis in mice deficient in AMP-activated protein kinase alpha subunits, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- Premisecitation
Administration of metformin before ischemia or at reperfusion decreased myocardial injury in mice.
“Administration of metformin before ischemia or at reperfusion decreased myocardial injury in mice [183].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [183] Calvert, 2008, Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling, Diabetes source
Not checked in the free run.
- Premisecitation
AMPK is essential for ischemic angiogenesis.
“AMPK has been proven to be essential for ischemic angiogenesis; however, the mechanism by which AMPK promotes angiogenesis is poorly elucidated [165].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [165] Nagata, 2003, AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress, J. Biol. Chem. source
Not checked in the free run.
- Premisecitation
Metformin failed to increase eNOS Ser1177 phosphorylation at reperfusion in AMPKα2 deficient mice.
“Further, metformin failed to increase eNOS Ser1177 phosphorylation at reperfusion in AMPKα2 deficient mice [183].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [183] Calvert, 2008, Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling, Diabetes source
Not checked in the free run.
- Premisecitation
Melatonin treatment reveals a protective role in cardiac microvasculature under I/R injury by activating AMPK.
“Melatonin treatment reveals a protective role in cardiac microvasculature under I/R injury by activating AMPK [134].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [134] Zhou, 2017, Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis, J. Pineal. Res. source
Not checked in the free run.
- Interpretationcitation
In endothelial cells, AMPK-dependent UCP2 expression together with eNOS phosphorylation promotes angiogenesis.
“Collectively, these results concluded that, in ECs, AMPK-dependent UCP2 expression together with eNOS phosphorylation promotes angiogenesis [132].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Xu, 2011, Impaired expression of uncoupling protein 2 causes defective postischemic angiogenesis in mice deficient in AMP-activated protein kinase alpha subunits, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- Premisecitation
AMPK agonist AICAR dramatically increased mitophagy.
“Notably, AMPK agonist AICAR dramatically increased mitophagy [133].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [133] Zhang, 2018, AMPK activation serves a critical role in mitochondria quality control via modulating mitophagy in the heart under chronic hypoxia, Int. J. Mol. Med.
Not checked in the free run.
- Premisecitation
Supplementation of PK11195 markedly reduced neointima formation in carotid arteries after balloon injury, through the suppression of the phenotype switching of VSMC.
“Supplementation of PK11195, a ligand of TSPO, markedly reduced neointima formation in carotid arteries after balloon injury, through the suppression of the phenotype switching of VSMC [137].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [137] Wu, 2020, TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation, Acta Pharmacol. Sin. source
Not checked in the free run.
- Premisecitation
Nitrite is a dietary constituent that protects the heart against I/R injury in many animal models during both ischemia and preconditioning stage.
“Nitrite is a dietary constituent that protects the heart against I/R injury in many animal models during both ischemia and preconditioning stage [186,187,188,189,190,191,192].”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [186] Duranski, 2005, Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver, J. Clin. Investig. source
Not checked in the free run.
- cites [187] Tripatara, 2007, Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: Role for xanthine oxidoreductase, J. Am. Soc. Nephrol. source
Not checked in the free run.
- cites [188] Jung, 2006, Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury, Stroke source
Not checked in the free run.
- cites [189] Dezfulian, 2007, Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics, Cardiovasc. Res. source
Not checked in the free run.
- cites [190] Webb, 2004, Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [191] Kumar, 2008, Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [192] Lundberg, 2008, The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics, Nat. Rev. Drug Discov. source
Not checked in the free run.
- Interpretationcitation
Activation of AMPK signaling is required for the cardioprotective effect of nitrite in the preconditioning stage of I/R.
“The activation of AMPK signaling is required for the cardioprotective effect of nitrite in the preconditioning stage of I/R [135].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [135] Mo, 2014, Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion, Cardiovasc. Res. source
Not checked in the free run.
- Premisecitation
Nitrite protected the heart against I/R injury through the activation of protein kinase A.
“Notably, in vivo animal study showed consistent results that nitrite protected the heart against I/R injury through the activation of protein kinase A [135].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [135] Mo, 2014, Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion, Cardiovasc. Res. source
Not checked in the free run.
- Premisecitation
MOTS-c treatment significantly attenuated VCs induced by vitamin D3 and nicotine.
“Study showed that MOTS-c treatment significantly attenuated VCs induced by vitamin D3 and nicotine [136].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [136] Wei, 2020, Mitochondrial-derived peptide MOTS-c attenuates vascular calcification and secondary myocardial remodeling via adenosine monophosphate-activated protein kinase signaling pathway, Cardiorenal. Med. source
Not checked in the free run.
- Premisecitation
In a model of balloon-injured carotid arteries, TSPO expression was dramatically increased in carotid arteries.
“In a model of balloon-injured carotid arteries, TSPO expression was dramatically increased in carotid arteries [136].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [136] Wei, 2020, Mitochondrial-derived peptide MOTS-c attenuates vascular calcification and secondary myocardial remodeling via adenosine monophosphate-activated protein kinase signaling pathway, Cardiorenal. Med. source
Not checked in the free run.
- Premisecitation
TSPO is involved in the aberrant VSMC proliferation after angioplasty.
“The translocator protein (TSPO), an 18 kDa protein located at the outer mitochondrial membrane, is involved in the aberrant VSMC proliferation after angioplasty [137].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [137] Wu, 2020, TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation, Acta Pharmacol. Sin. source
Not checked in the free run.
- Interpretationcitation
MOTS-c may act as an inhibitor of VCs via suppressing the expression of AT1 and ETB receptors, probably by activating AMPK signaling.
“These findings indicate that MOTS-c may act as an inhibitor of VCs via suppressing the expression of AT1 and ETB receptors, probably by activating AMPK signaling [136].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [136] Wei, 2020, Mitochondrial-derived peptide MOTS-c attenuates vascular calcification and secondary myocardial remodeling via adenosine monophosphate-activated protein kinase signaling pathway, Cardiorenal. Med. source
Not checked in the free run.
- Premisecitation
In cultured rat H9c2 cardiomyoblasts treated with H/R, preconditioning with nitrite markedly attenuated cell death following hypoxia.
“In cultured rat H9c2 cardiomyoblasts treated with H/R, preconditioning with nitrite markedly attenuated cell death following hypoxia [135].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [135] Mo, 2014, Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion, Cardiovasc. Res. source
Not checked in the free run.
- Premisecitation
AMPK-specific inhibitor compound C abolished PK11195-induced inhibition of the proliferation and migration of platelet-derived growth factor-BB-treated A10 cells.
“An AMPK-specific inhibitor, compound C, abolished PK11195-induced inhibition of the proliferation and migration of platelet-derived growth factor-BB-treated A10 cells [137].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [137] Wu, 2020, TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation, Acta Pharmacol. Sin. source
Not checked in the free run.
- Premisecitation
PK11195 activated AMPK in A10 cells in a dose-dependent manner.
“Furthermore, it was found that PK11195 activated AMPK in A10 cells in a dose-dependent manner.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [137] Wu, 2020, TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation, Acta Pharmacol. Sin. source
Not checked in the free run.
- Premisecitation
ETB and AT1 are involved in AMPK pathway by binding to their receptors.
“ETB and AT1 are reportedly involved in AMPK pathway by binding to their receptors [194,195].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [194] Kim, 2017, Angiotensin II affects inflammation mechanisms via AMPK-related signalling pathways in HL-1 atrial myocytes, Sci. Rep. source
Not checked in the free run.
- cites [195] Chen, 2018, Homocysteine up-regulates ETB receptors via suppression of autophagy in vascular smooth muscle cells, Microvasc. Res. source
Not checked in the free run.
- Premisecitation
All beneficial effects of melatonin on microvasculature were abolished in AMPKα null mice.
“Notably, all the beneficial effects of melatonin on microvasculature were abolished in AMPKα null mice [134].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [134] Zhou, 2017, Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis, J. Pineal. Res. source
Not checked in the free run.
- Premisecitation
Activation of AMPK by AICAR or metformin protects the heart from cardiac hypertrophy induced by aging and other stresses.
“Activation of AMPK by AICAR or metformin protects the heart from cardiac hypertrophy induced by aging and other stresses [202].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [202] Turdi, 2010, AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction, Aging Cell source
Not checked in the free run.
- Premisecitation
AMPK deletion promoted mitochondrial fragmentation in endothelial cells by inhibiting the autophagy-dependent degradation of DRP1.
“Studies showed that AMPK deletion promoted mitochondrial fragmentation in ECs by inhibiting the autophagy-dependent degradation of DRP1 [105].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [105] Wang, 2017, Deletion of PRKAA triggers mitochondrial fission by inhibiting the autophagy-dependent degradation of DNM1L, Autophagy source
Not checked in the free run.
- Premisecitation
The most studied mechanism for mitophagy in mammalian cells is mediated by the cytoplasmic E3 ubiquitin ligase PARKIN and the mitochondrial membrane kinase PINK1.
“The most studied mechanism for mitophagy in mammalian cells is mediated by the cytoplasmic E3 ubiquitin ligase PARKIN [210] and the mitochondrial membrane kinase PINK1 [211].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
This phosphorylation proved critical for the efficient recruitment of PARKIN to mitochondria to initiate mitophagy during HF.
“This phosphorylation proved critical for the efficient recruitment of PARKIN to mitochondria to initiate mitophagy during HF [117].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Wang, 2018, AMPKalpha2 protects against the development of heart failure by enhancing mitophagy via pink1 phosphorylation, Circ. Res. source
Not checked in the free run.
- Premisecitation
AMPKα2−/− mice showed an exacerbated progression of TAC-induced HF through defected cardiac mitophagy.
“In contrast, AMPKα2−/− mice showed an exacerbated progression of TAC-induced HF through defected cardiac mitophagy [117].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Wang, 2018, AMPKalpha2 protects against the development of heart failure by enhancing mitophagy via pink1 phosphorylation, Circ. Res. source
Not checked in the free run.
- Premisecitation
Mitochondrial dynamics plays a pivotal role in endothelial dysfunction during macrovascular complications.
“A line of evidence indicates that mitochondrial dynamics plays a pivotal role in endothelial dysfunction during macrovascular complications [220,221].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [220] Forbes, 2017, Vascular complications in diabetes: Old messages, new thoughts, Diabetologia source
Not checked in the free run.
- cites [221] LaRocca, 2014, Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice, J. Physiol. source
Not checked in the free run.
- Premisecitation
Mitochondria are a susceptible target of oxidative damage, which causes a malicious circle of events in endothelial cells.
“Additionally, mitochondria are a susceptible target of oxidative damage, which causes a malicious circle of events in ECs [224,225,226].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [224] Shigenaga, 1994, Oxidative damage and mitochondrial decay in aging, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [225] Green, 2004, Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes, Diabetes source
Not checked in the free run.
- cites [226] Brand, 2016, Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling, Free Radic. Biol. Med. source
Not checked in the free run.
- Premisecitation
Ser495 in PINK1 underwent phosphorylation by AMPKα2 upon the dissipation of the ΔΨm in cardiomyocytes.
“Further, ser495 in PINK1 underwent phosphorylation by AMPKα2 upon the dissipation of the ΔΨm in cardiomyocytes [117].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Wang, 2018, AMPKalpha2 protects against the development of heart failure by enhancing mitophagy via pink1 phosphorylation, Circ. Res. source
Not checked in the free run.
- Premisecitation
Numerous anti-diabetic agents may improve endothelial function by targeting AMPK to impact mitochondrial dynamics.
“Numerous anti-diabetic agents may improve endothelial function by targeting AMPK to impact mitochondrial dynamics [227].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [227] Lu, 2019, AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases, Biosci. Rep. source
Not checked in the free run.
- Premisecitation
SIRT5 plays a vital role in mitochondrial function via increased mitochondrial nicotinamide adenine dinucleotide and ATP synthase activity.
“SIRT5, primarily localizing at the mitochondrial matrix, plays a vital role in mitochondrial function via increased mitochondrial nicotinamide adenine dinucleotide and ATP synthase activity [138].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [138] Zhang, M., Wu, J., Sun, R., Tao, X., Wang, X., Kang, Q., Wang, H., Zhang, L., Liu, P., and Zhang, J. (2019). SIRT5 deficiency suppresses mitochondrial ATP production and promotes AMPK activation in response to energy stress. PLoS ONE, 14. source
Not checked in the free run.
- Premisecitation
AMPK deficiency contributes to cardiac hypertrophy induced by aging, neurohumoral activation, pressure overload, and MI.
“Furthermore, AMPK deficiency also contributes to cardiac hypertrophy induced by aging, neurohumoral activation, pressure overload, and MI [201].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [201] Zaha, 2012, AMP-activated protein kinase regulation and biological actions in the heart, Circ. Res. source
Not checked in the free run.
- Premisecitation
In diabetes, mitochondrial dysfunction induces and aggravates macrovascular complications.
“In diabetes, mitochondrial dysfunction induces and aggravates macrovascular complications [218,219].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [218] Wang, 2017, Metformin suppresses diabetes-accelerated atherosclerosis via the inhibition of drp1-mediated mitochondrial fission, Diabetes source
Not checked in the free run.
- cites [219] Sorrentino, 2018, Repairing mitochondrial dysfunction in disease, Annu. Rev. Pharmacol. Toxicol. source
Not checked in the free run.
- Premisecitation
AMPKα2 regulates PINK1-PARKIN-dependent mitophagy in pressure overload-induced cardiac hypertrophy and HF models.
“Recently, studies in pressure overload-induced cardiac hypertrophy and HF models highlight the role of AMPKα2 in the regulation of PINK1–PARKIN-dependent mitophagy [117].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Wang, 2018, AMPKalpha2 protects against the development of heart failure by enhancing mitophagy via pink1 phosphorylation, Circ. Res. source
Not checked in the free run.
- Premisecitation
Mitophagy impairment can induce cardiomyocyte death and HF.
“Accumulating evidence suggests that mitophagy impairment can induce cardiomyocyte death and HF [206,207,208,209].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [206] Tong, 2019, Mitophagy is essential for maintaining cardiac function during high fat diet-induced diabetic cardiomyopathy, Circ. Res. source
Not checked in the free run.
- cites [207] Cahill, 2016, Resistance of dynamin-related protein 1 oligomers to disassembly impairs mitophagy, resulting in myocardial inflammation and heart failure, J. Biol. Chem. source
Not checked in the free run.
- cites [208] Ikeda, 2015, Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress, Circ. Res. source
Not checked in the free run.
- cites [209] Oka, 2012, Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure, Nature source
Not checked in the free run.
- Premisecitation
Adenovirus overexpression of AMPKα2 in hearts blocked TAC-induced chronic HF via promoting mitophagy and mitochondrial function.
“The adenovirus overexpression of AMPKα2 in hearts blocked TAC-induced chronic HF via promoting mitophagy and mitochondrial function [117].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Wang, 2018, AMPKalpha2 protects against the development of heart failure by enhancing mitophagy via pink1 phosphorylation, Circ. Res. source
Not checked in the free run.
- Premisecitation
Cardiac LKB1 null mice are associated with hypertrophy.
“In parallel, cardiac LKB1 null mice are associated with hypertrophy [200].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [200] Ikeda, 2009, Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction, J. Biol. Chem. source
Not checked in the free run.
- Premisecitation
SIRT5 removes posttranslational modifications including malonylation, glutarylation, and succinylation on lysine residues.
“SIRT5, a member of the nicotinamide adenine dinucleotide-dependent sirtuin family of protein deacetylases, removes posttranslational modifications including malonylation, glutarylation, and succinylation on lysine residues [204,205].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [204] Schlicker, 2008, Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5, J. Mol. Biol. source
Not checked in the free run.
- cites [205] Nakagawa, 2009, SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle, Cell source
Not checked in the free run.
- Premisecitation
Empagliflozin exerted its protective roles via inhibition of AMPK-dependent mitochondrial fission.
“Empagliflozin exerted its protective roles via inhibition of AMPK-dependent mitochondrial fission [229].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [229] Zhou, 2018, Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission, Redox Biol. source
Not checked in the free run.
- Premisecitation
Empagliflozin recovered the AMP-to-ATP ratio that is necessary for triggering AMPK activation.
“Empagliflozin recovered the AMP-to-ATP ratio that is necessary for triggering AMPK activation [229].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [229] Zhou, 2018, Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission, Redox Biol. source
Not checked in the free run.
- Premisecitation
Endothelial dysfunction is considered a core modulator of vascular impairment in diabetes.
“Endothelial dysfunction, the initial step of CVDs, is considered as a core modulator of vascular impairment in diabetes [215].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [215] Forbes, 2013, Mechanisms of diabetic complications, Physiol. Rev. source
Not checked in the free run.
- Premisecitation
AICAR plays anti-inflammatory roles in vascular cells both in vitro and in vivo.
“Additionally, AICAR, an AMPK activator, plays anti-inflammatory roles in vascular cells both in vitro and in vivo [248,249,250].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [248] Ewart, 2008, Inhibition of tumor necrosis factor alpha-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- cites [249] Zhang, 2011, AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- cites [250] Hawley, 2002, The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism, Diabetes source
Not checked in the free run.
- Premisecitation
DRP1-dependent mitochondrial fission triggered mitochondrial apoptotic pathway, as shown by the caspase 9 cleavage, ΔΨm decline, cytochrome c leakage, as well as increased expression of proapoptotic proteins.
“DRP1-dependent mitochondrial fission triggered mitochondrial apoptotic pathway, as shown by the caspase 9 cleavage, ΔΨm decline, cytochrome c leakage, as well as increased expression of proapoptotic proteins [140].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] Cui, 2018, Melatonin alleviates inflammation-induced apoptosis in human umbilical vein endothelial cells via suppression of Ca(2+)-XO-ROS-Drp1-mitochondrial fission axis by activation of AMPK/SERCA2a pathway, Cell Stress Chaperones source
Not checked in the free run.
- Interpretationcitation
Inflammation, NO bioavailability, insulin resistance, and oxLDL are the main participating factors in obesity-related endothelial dysfunction.
“Collectively, inflammation, NO bioavailability, insulin resistance, and oxLDL are the main participating factors in obesity-related endothelial dysfunction [261].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [261] Engin, 2017, Endothelial dysfunction in obesity, Adv. Exp. Med. Biol. source
Not checked in the free run.
- Premisecitation
Melatonin protected HUVECs against lipopolysaccharide-mediated apoptosis.
“For instance, melatonin protected HUVECs against lipopolysaccharide-mediated apoptosis [140].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] Cui, 2018, Melatonin alleviates inflammation-induced apoptosis in human umbilical vein endothelial cells via suppression of Ca(2+)-XO-ROS-Drp1-mitochondrial fission axis by activation of AMPK/SERCA2a pathway, Cell Stress Chaperones source
Not checked in the free run.
- Premisecitation
Vascular inflammation stimulates the production of chemoattractants and molecules such as monocyte chemotactic proteins and vascular cell adhesion molecule 1 in endothelium.
“Vascular inflammation stimulates the production of chemoattractants and molecules such as monocyte chemotactic proteins and vascular cell adhesion molecule 1 in endothelium [242,243,244].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [242] Marui, 1993, Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells, J. Clin. Investig. source
Not checked in the free run.
- cites [243] Murao, 2000, TNF-alpha stimulation of MCP-1 expression is mediated by the Akt/PKB signal transduction pathway in vascular endothelial cells, Biochem. Biophys. Res. Commun. source
Not checked in the free run.
- cites [244] Kirii, 2003, Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- Premisecitation
AMPK exerted its anti-inflammatory roles on the vasculature partially via the inhibition of adhesion molecules and chemoattractants by regulating signal transducer and activator of transcription 3, of nuclear factor kappa B, and p300 pathways.
“Indeed, studies have uncovered that AMPK exerted its anti-inflammatory roles on the vasculature partially via the inhibition of adhesion molecules and chemoattractants [248,249,252,253] by regulating signal transducer and activator of transcription 3, of nuclear factor kappa B, and p300 pathways [254,255,256].”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [248] Ewart, 2008, Inhibition of tumor necrosis factor alpha-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- cites [249] Zhang, 2011, AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- cites [252] Nerstedt, 2010, AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3), Diabetologia source
Not checked in the free run.
- cites [253] Salminen, 2011, AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: Impact on healthspan and lifespan, J. Mol. Med. (Berl) source
Not checked in the free run.
- cites [254] Gongol, 2013, AMPKalpha2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [255] Hattori, 2006, Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells, Hypertension source
Not checked in the free run.
- cites [256] Mancini, 2018, Canagliflozin inhibits interleukin-1beta-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms, Sci. Rep. source
Not checked in the free run.
- Premisecitation
Similar general outcome of metformin, AICAR, atheroprotective flow, and statins on endothelial cells can be found through AMPK activation.
“As discussed previously, a similar general outcome of metformin, AICAR, atheroprotective flow, and statins on ECs can be found through AMPK activation [245,250,251].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [245] Zhang, 2006, AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- cites [250] Hawley, 2002, The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism, Diabetes source
Not checked in the free run.
- cites [251] Li, 2008, AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- Interpretationcitation
AMPK activation, likely via downregulation of FUNDC1-related MAMs, represents a new therapeutic avenue for treating DCM.
“These findings illustrating the results of AMPK activation, likely via downregulation of FUNDC1-related MAMs, represent a new therapeutic avenue for treating DCM [139].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [139] Wu, 2019, Hyperglycemia-Driven Inhibition of AMP-activated protein kinase alpha2 induces diabetic cardiomyopathy by promoting mitochondria-associated endoplasmic reticulum membranes in vivo, Circulation source
Not checked in the free run.
- Premisecitation
FFAs also contribute to a higher production of ROS and inflammation in endothelial cells.
“FFAs also contribute to a higher production of ROS and inflammation in ECs [260].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [260] Inoguchi, 2000, High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells, Diabetes source
Not checked in the free run.
- Premisecitation
Melatonin induced endothelial cell apoptosis through activation of the AMPK-sarcoplasmic/endoplasmic reticulum calcium ATPase 2a pathway under conditions of inflammation.
“Collectively, this study demonstrated that melatonin induced endothelial cell apoptosis through activation of the AMPK-sarcoplasmic/endoplasmic reticulum calcium ATPase 2a pathway under conditions of inflammation [140].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [140] Cui, 2018, Melatonin alleviates inflammation-induced apoptosis in human umbilical vein endothelial cells via suppression of Ca(2+)-XO-ROS-Drp1-mitochondrial fission axis by activation of AMPK/SERCA2a pathway, Cell Stress Chaperones source
Not checked in the free run.
- Premisecitation
AMPK activation reversed DCM by suppressing high glucose-induced MAM formation, mitochondrial Ca2+ increase, and mitochondrial dysfunction in cultured mouse neonatal cardiomyocytes.
“In addition, AMPK activation reversed DCM by suppressing high glucose-induced MAM formation, mitochondrial Ca2+ increase, and mitochondrial dysfunction in cultured mouse neonatal cardiomyocytes 139].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [139] Wu, 2019, Hyperglycemia-Driven Inhibition of AMP-activated protein kinase alpha2 induces diabetic cardiomyopathy by promoting mitochondria-associated endoplasmic reticulum membranes in vivo, Circulation source
Not checked in the free run.
- Premisecitation
AMPK has potent anti-inflammatory properties in hypertension.
“Recently, deep mechanistic studies into the cardiovascular protection of AMPK using endothelial or myelomonocytic cell-specific AMPK KO mice have revealed the potent anti-inflammatory properties of AMPK in hypertension [145].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [145] Jansen, T., Kvandová, M., Daiber, A., Stamm, P., Frenis, K., Schulz, E., Münzel, T., and Kröller-Schön, S. (2020). The AMP-activated protein kinase plays a role in antioxidant defense and regulation of vascular inflammation. Antioxidants (Basel), 9. source
Not checked in the free run.
- Premisecitation
Metformin has been proven as an anti-inflammatory, especially for the inflammation in diabetes and following postsurgical endotoxin.
“Metformin has been proven as an anti-inflammatory, especially for the inflammation in diabetes and following postsurgical endotoxin [245,246,247].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [245] Zhang, 2006, AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
- cites [246] Caballero, 2004, The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: A placebo-controlled, randomized clinical trial, J. Clin. Endocrinol. Metab. source
Not checked in the free run.
- cites [247] Bergheim, 2006, Metformin prevents endotoxin-induced liver injury after partial hepatectomy, J. Pharmacol. Exp. Ther. source
Not checked in the free run.
- Premisecitation
Punicalagin was the main component of pomegranate extract that specifically activated AMPK in cardiomyocytes via quickly reducing the intracellular ATP-to-ADP ratio.
“Cell culture study demonstrated that punicalagin was the main component of pomegranate extract that specifically activated AMPK in cardiomyocytes via quickly reducing the intracellular ATP-to-ADP ratio [142].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [142] Cao, 2015, Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation, Sci. Rep. source
Not checked in the free run.
- Premisecitation
A recent study of subjects with type 2 diabetes offered clear evidence of mitochondrial dysfunction in permeabilized right atrial cardiac fibers.
“A recent study of subjects with type 2 diabetes offered clear evidence of mitochondrial dysfunction in permeabilized right atrial cardiac fibers [271], suggesting improvement to mitochondrial function as a potential therapeutic strategy for obesity and its associated pathologies.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [271] Anderson, 2009, Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart, J. Am. Coll. Cardiol. source
Not checked in the free run.
- Premisecitation
Corosolic acid suppressed DRP1 activation by inducing DRP1 phosphorylation at Ser637, thus inhibiting mitochondrial fission in endothelial cells in response to palmitate treatment.
“CRA suppressed DRP1 activation by inducing DRP1 phosphorylation at Ser637, thus inhibiting mitochondrial fission in ECs in response to palmitate (PA) treatment [141].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [141] Li, 2016, Inhibition of mitochondrial fission and NOX2 expression prevent nlrp3 inflammasome activation in the endothelium: The role of corosolic acid action in the amelioration of endothelial dysfunction, Antioxid. Redox Signal. source
Not checked in the free run.
- Premisecitation
Corosolic acid suppressed PA-induced NOX2 activation, which was revealed by the reduced migration of p47phox to cell membrane and inhibition of gp91phox expression.
“Concurrently, CRA suppressed PA-induced NOX2 activation, which was revealed by the reduced migration of p47phox to cell membrane and inhibition of gp91phox expression [141].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [141] Li, 2016, Inhibition of mitochondrial fission and NOX2 expression prevent nlrp3 inflammasome activation in the endothelium: The role of corosolic acid action in the amelioration of endothelial dysfunction, Antioxid. Redox Signal. source
Not checked in the free run.
- Premisecitation
In Sprague Dawley rats, administration of pomegranate extract, composed of 40% punicalagin, effectively blocked HFD-induced cardiac accumulation of fat and myocardial damage.
“In Sprague Dawley rats, administration of pomegranate extract, composed of 40% punicalagin, effectively blocked HFD-induced cardiac accumulation of fat (e.g., cholesterol and triglycerides) and myocardial damage [142].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [142] Cao, 2015, Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation, Sci. Rep. source
Not checked in the free run.
- Premisecitation
AMPK activity was observed to be suppressed by high-fat diet in diverse tissues, including white heart, adipose tissue, and liver.
“AMPK activity was observed to be suppressed by high-fat diet (HFD) in diverse tissues, including white heart, adipose tissue, and liver [266].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [266] Lindholm, 2013, A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats, J. Physiol. Biochem. source
Not checked in the free run.
- Premisecitation
Corosolic acid alleviated endothelial inflammation in obesity by activating AMPK.
“Study showed that CRA alleviated endothelial inflammation in obesity by activating AMPK [141].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [141] Li, 2016, Inhibition of mitochondrial fission and NOX2 expression prevent nlrp3 inflammasome activation in the endothelium: The role of corosolic acid action in the amelioration of endothelial dysfunction, Antioxid. Redox Signal. source
Not checked in the free run.
- Interpretationcitation
Punicalagin, by activating AMPK, prevented HFD-related cardiac disorders via modulating mitochondria as well as phase II enzymes.
“These findings collectively elucidated that punicalagin, by activating AMPK, prevented HFD-related cardiac disorders via modulating mitochondria as well as phase II enzymes [142].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [142] Cao, 2015, Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation, Sci. Rep. source
Not checked in the free run.
- Premisecitation
HFD-induced AMPK deficiency contributed to the enhanced cardiomyocyte death in myocardial ischemia.
“HFD-induced AMPK deficiency contributed to the enhanced cardiomyocyte death in myocardial ischemia [267].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [267] Shao, 2014, A redox-dependent mechanism for regulation of AMPK activation by thioredoxin1 during energy starvation, Cell Metab. source
Not checked in the free run.
- May combine two claims. 71
- Classified as probably not a substantial claim. 21
May combine two claims.
Interpretationnone givenAMPK is a redox sensor and modulator that plays pivotal roles in maintaining cardiovascular processes and inhibiting disease progression.
“In addition to its conventional roles as an intracellular energy switch or fuel gauge, emerging research has shown that AMPK is also a redox sensor and modulator, playing pivotal roles in maintaining cardiovascular processes and inhibiting disease progression.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn humans, each AMPK subunit has multiple distinct isoforms encoded by different genes: α1 and α2 by PRKAA1 and PRKAA2; β1 and β2 by PRKAB1 and PRKAB2; γ1, γ2, and γ3 by PRKAG1, PRKAG2, and PRKAG3.
“In humans, each subunit has multiple distinct isoforms encoded by different genes: the α-subunit has two isoforms, α1 and α2, encoded by gene PRKAA1 and PRKAA2, respectively [20]; the β-subunit has two isoforms, β1 and β2, encoded by gene PRKAB1 and PRKAB2, respectively [21]; and the γ-subunit has three isoforms, γ1, γ2, and γ3, encoded by gene PRKAG1, PRKAG2, and PRKAG3, respectively [22].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [20] Stapleton, 1996, Mammalian AMP-activated protein kinase subfamily, J. Biol. Chem. source
Not checked in the free run.
- cites [21] Thornton, 1998, Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle, J. Biol. Chem. source
Not checked in the free run.
- cites [22] Cheung, 2000, Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding, Biochem. J. source
Not checked in the free run.
May combine two claims.
PremisecitationActivation loop phosphorylation increases AMPK activity by about 100-fold, while allosteric regulation changes AMPK activity up to tenfold in mammalian cells and about twofold in recombinant, bacterially produced AMPK.
“Activation loop phosphorylation increases AMPK activity by about 100-fold, while allosteric regulation changes AMPK activity up to tenfold in mammalian cells and about twofold in recombinant, bacterially produced AMPK [26,28,38,39].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [26] Xiao, 2007, Structural basis for AMP binding to mammalian AMP-activated protein kinase, Nature source
Not checked in the free run.
- cites [28] Gowans, 2013, AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation, Cell Metab. source
Not checked in the free run.
- cites [38] Sanders, 2007, Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family, J. Biol. Chem. source
Not checked in the free run.
- cites [39] Davies, 1995, 5’-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC, FEBS Lett. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationROS are free radicals and chemically reactive molecules derived from oxygen.
“ROS are plenty of free radicals and chemically reactive molecules derived from oxygen molecule [41].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Alfadda, 2012, Reactive oxygen species in health and disease, J. Biomed. Biotechnol. source
Not checked in the free run.
May combine two claims.
Premisenone givenAccumulating studies have demonstrated crosstalk between AMPK and mitochondria, such as AMPK regulation of mitochondrial homeostasis and mitochondrial dysfunction causing abnormal AMPK activity.
“Accumulating studies have demonstrated crosstalk between AMPK and mitochondria, such as AMPK regulation of mitochondrial homeostasis and mitochondrial dysfunction causing abnormal AMPK activity.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAll possible combinations of AMPK subunits produce 12 different AMPK complexes.
“Each AMPK complex is comprised of an α-subunit, a β-subunit, and a γ-subunit, and all possible combinations produce 12 different AMPK complexes [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Ross, 2016, AMP-activated protein kinase: A cellular energy sensor that comes in 12 flavours, FEBS J. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe γ-subunit includes four tandem cystathionine β synthase motifs that allow AMPK to bind adenine nucleotides and react to changes in AMP, ADP, and ATP.
“The γ-subunit allows AMPK to react to changes in the level of AMP, ADP, and ATP, as it includes four tandem cystathionine β synthase motifs that allow AMPK to bind adenine nucleotides [26].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Xiao, 2007, Structural basis for AMP binding to mammalian AMP-activated protein kinase, Nature source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExcessive production of ROS, usually termed oxidative stress, is caused by increased production and/or insufficient presence of endogenous antioxidants.
“Excessive production of ROS, usually termed oxidative stress, are caused by increased production and/or insufficient presence of endogenous antioxidants [41].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Alfadda, 2012, Reactive oxygen species in health and disease, J. Biomed. Biotechnol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMost ROS are generated as byproducts of mitochondrial electron transportation from the reduction of molecular oxygen to produce superoxide.
“Most ROS are generated as byproducts of mitochondrial electron transportation from the reduction of molecular oxygen to produce superoxide [41].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Alfadda, 2012, Reactive oxygen species in health and disease, J. Biomed. Biotechnol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOxidative stress damages fats, DNA, and proteins in a cell, which can lead to diseases such as diabetes, cancer, neurodegenerative disease, and cardiovascular disease.
“Oxidative stress is considered detrimental because of its damage to fats, deoxyribonucleic acid, and proteins in a cell, which can lead to numerous diseases such as diabetes, cancer, neurodegenerative disease, and cardiovascular disease (CVD) [41].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Alfadda, 2012, Reactive oxygen species in health and disease, J. Biomed. Biotechnol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAMPK is a heterotrimeric complex composed of a catalytic α-subunit and β and γ regulatory subunits.
“AMPK, a heterotrimeric complex, is composed of a catalytic α-subunit and beta (β) and gamma (γ) regulatory subunits [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Yan, Y., Zhou, X.E., Xu, H.E., and Melcher, K. (2018). Structure and physiological regulation of AMPK. Int. J. Mol. Sci., 19. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe β-subunit includes a carbohydrate-binding module that grants AMPK the ability to bind glycogen.
“The β-subunit includes a carbohydrate-binding module that grants AMPK to bind to glycogen [25].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Hudson, 2003, A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias, Curr. Biol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAllosteric AMPK activation can occur in non-phosphorylated AMPK, with even higher fold activation than phosphorylated AMPK.
“Lastly, allosteric AMPK activation can also occur in non-phosphorylated AMPK, with even higher fold activation than phosphorylated AMPK [40].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Willows, 2017, Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells, Biochem. J. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDouble knockout of AMPKα1 and AMPKα2 in mice gives rise to embryonic lethality.
“The α-subunit is essential, and a double knockout (KO) of AMPKα1 and AMPKα2 in mice gives rise to embryonic lethality [24].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Viollet, 2009, AMPK: Lessons from transgenic and knockout animals, Front. Biosci. (Landmark Ed.) source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe α-subunit contains the kinase domain and a critical residue (Thr174 in α1 and Thr172 in α2) that is phosphorylated by upstream kinases.
“The α-subunit contains the kinase domain and a critical residue (Thr174 in α1-subunit and Thr172 in α2-subunit, hereafter referred to as Thr172) that is phosphorylated by upstream kinases [1].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Hardie, 2012, AMPK: A nutrient and energy sensor that maintains energy homeostasis, Nat. Rev. Mol. Cell Biol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLKB1 and CAMKK2 are the two main mammalian upstream molecules that phosphorylate AMPK.
“Liver kinase B 1 (LKB1) [32] and calcium/calmodulin-dependent protein kinase kinase (CAMKK) 2 [33,34] can be employed as the two main mammalian upstream molecules that phosphorylate AMPK.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [32] Woods, 2003, LKB1 is the upstream kinase in the AMP-activated protein kinase cascade, Curr. Biol. source
Not checked in the free run.
- cites [33] Fujiwara, 2016, Differential AMP-activated Protein Kinase (AMPK) Recognition mechanism of Ca2+/calmodulin-dependent protein kinase kinase isoforms, J. Biol. Chem. source
Not checked in the free run.
- cites [34] Hawley, 2005, Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase, Cell Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationIn H4IIEC3 cells, exogenous hydrogen peroxide transiently increased phosphor-AMPK by LKB1 signaling, while in HeLa cells it promoted AMPK phosphorylation by CaMKK signaling.
“In H4IIEC3 cells, exogenous hydrogen peroxide transiently increased the level of phosphor-AMPK by LKB1 signaling, while exogenous hydrogen peroxide promoted AMPK phosphorylation in HeLa cells by CaMKK signaling [42].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Liangpunsakul, 2008, Effect of ethanol on hydrogen peroxide-induced AMPK phosphorylation, Am. J. Physiol. Gastrointest. Liver Physiol. source
Not checked in the free run.
May combine two claims.
PremisecitationTPr agonist-activated AMPK is mediated by hydrogen peroxide, as overexpression of catalase abolished TPr agonist-induced AMPK activation.
“TPr agonists-activated AMPK was mediated by hydrogen peroxide, as demonstrated by the results showing overexpression of catalase (CAT) abolished Tpr agonists-induced AMPK activation [61].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Zhang, 2008, Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide, Circ. Res. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExogenous or glucose oxidase-generated hydrogen peroxide induced direct S-glutathionylation on the AMPKα subunit at Cys299 and Cys304, which contributes to AMPK activation.
“Exogenous or glucose oxidase-generated hydrogen peroxide induced direct S-glutathionylation on the AMPKα subunit at Cys299 and Cys304, which contributes to AMPK activation [48].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Zmijewski, 2010, Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase, J. Biol. Chem. source
Not checked in the free run.
May combine two claims.
PremisecitationDecreased NO bioavailability occurs in response to lipid infiltration, oxidative stress, and inflammatory factors, which play a vital role in endothelial dysfunction.
“Its decrease occurs in response to lipid infiltration, oxidative stress, and inflammatory factors, which play a vital role in endothelial dysfunction [153].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [153] Chen, 2018, Nitric oxide bioavailability dysfunction involves in atherosclerosis, Biomed. Pharmacother. source
Not checked in the free run.
May combine two claims.
PremisecitationAMPK negatively regulates NOX by reducing its phosphorylation and preventing P47phox's translocation to membrane.
“Additional evidence supporting AMPK protection against oxidative stress is that AMPK negatively regulates NOX by reducing its phosphorylation and preventing P47phox’s translocation to membrane [70,151].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [70] Wang, 2010, AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: Role of 26S proteasomes, Circ. Res. source
Not checked in the free run.
- cites [151] McCarty, 2009, AMP-activated kinase may suppress NADPH oxidase activation in vascular tissues, Med. Hypotheses source
Not checked in the free run.
May combine two claims.
PremisecitationSuppression of oxidative stress blunted activation of the protein kinase B-cyclic AMP-responsive element binding protein-PGC1α pathway, which ameliorated mitochondrial dysfunction and apoptosis.
“Moreover, the suppression of oxidative stress, in turn, blunted the activation of the protein kinase B-cyclic AMP-responsive element binding protein–PGC1α pathway, which ameliorated mitochondrial dysfunction and apoptosis [129].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] Ou, 2019, Fucoxanthin protects against oxLDL-induced endothelial damage via activating the AMPK-Akt-CREB-PGC1alpha pathway, Mol. Nutr. Food Res. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome studies showed that ROS directly activated AMPK independent of changes in ADP, AMP, and ATP.
“Alternatively, some studies showed that ROS directly activated AMPK independent of changes in ADP, AMP, and ATP.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAMPK suppresses protein kinase C activity and prevents protein kinase C modulation of p47phox phosphorylation.
“AMPK suppresses protein kinase C activity and prevents protein kinase C modulation of p47phox phosphorylation [152].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [152] Ou, 2013, Ginkgo biloba extract attenuates oxLDL-induced endothelial dysfunction via an AMPK-dependent mechanism, J. Appl. Physiol. (1985) source
Not checked in the free run.
May combine two claims.
InterpretationreasoningROS-induced energy stress strongly activates AMPK, which is likely the main mechanism of ROS-mediated AMPK activation.
“It is well established that the ROS-induced energy stress strongly activates AMPK, which is likely the main mechanism of ROS-mediated AMPK activation.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn NIH-3T3 cells, exogenous hydrogen peroxide transiently activated AMPK in a dose-dependent manner, associated with an increased AMP-to-ATP ratio.
“Similarly, in NIH-3T3 cells, exogenous hydrogen peroxide transiently activated AMPK in a dose-dependent manner, which was associated with an increased AMP-to-ATP ratio [45].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Choi, 2001, The regulation of AMP-activated protein kinase by H(2)O(2), Biochem. Biophys. Res. Commun. source
Not checked in the free run.
May combine two claims.
PremisecitationVasculature I/R injury alleviates the efficiency of reperfusion therapy and compromises the clinical benefits of patients with acute MI.
“Vasculature I/R injury alleviates the efficiency of reperfusion therapy and compromises the clinical benefits of patients with acute MI [181].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [181] Ndrepepa, 2010, 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction, J. Am. Coll. Cardiol. source
Not checked in the free run.
May combine two claims.
PremisecitationWith increasing mitochondria, the level of ROS is also increased as mitochondrial byproducts, which can result in oxidative damage of mitochondria.
“However, with increasing mitochondria, the level of ROS is also increased as mitochondrial byproducts, which can result in oxidative damage of mitochondria [176].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [176] Fischer, 2012, Mitochondrial quality control: An integrated network of pathways, Trends Biochem. Sci. source
Not checked in the free run.
May combine two claims.
PremisecitationMitochondria-targeted esculetin greatly alleviated angiotensin II-induced monocyte infiltration, atherosclerotic plaque formation, and serum pro-inflammatory cytokine production in apolipoprotein E KO mice.
“Mitochondria-targeted esculetin, capable of scavenging mitochondrial ROS, greatly alleviated angiotensin II-induced monocyte infiltration, atherosclerotic plaque formation, and serum pro-inflammatory cytokine production in apolipoprotein E KO mice [131].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [131] Karnewar, 2016, Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: Potential implications in atherosclerosis, Sci. Rep. source
Not checked in the free run.
May combine two claims.
PremisecitationDuring early reperfusion, treatment with metformin augmented I/R-induced AMPK activation and significantly increased eNOS phosphorylation at ser1177.
“During early reperfusion, treatment with metformin augmented I/R-induced AMPK activation and significantly increased eNOS phosphorylation at ser1177 [183].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [183] Calvert, 2008, Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling, Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationApoptosis induces endothelial swelling, microvascular spasms, and capillary obstruction, which slows or even stops microcirculation blood flow following reperfusion.
“The apoptosis induces endothelial swelling, microvascular spasms, and capillary obstruction, which slows or even stops microcirculation blood flow following reperfusion [179].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [179] Kloner, 1974, The “no-reflow” phenomenon after temporary coronary occlusion in the dog, J. Clin. Investig. source
Not checked in the free run.
May combine two claims.
InterpretationcitationAMPK participates in mitophagy regulation, which thereby provides a valuable therapeutic target for ischemic heart diseases.
“These results suggest that AMPK participates in mitophagy regulation, which thereby provides a valuable therapeutic target for ischemic heart diseases.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [133] Zhang, 2018, AMPK activation serves a critical role in mitochondria quality control via modulating mitophagy in the heart under chronic hypoxia, Int. J. Mol. Med.
Not checked in the free run.
May combine two claims.
PremisecitationTube formation in mouse arterial endothelial cells isolated from either AMPKα1−/− or AMPKα2−/− mice was significantly impaired, exhibiting oxidative stress and reduced expression of UCP2.
“Similarly, in comparison with the WT cells, tube formation in mouse arterial endothelial cells isolated from either AMPKα1−/− or AMPKα2−/− mice was significantly impaired, exhibiting oxidative stress and reduced expression of UCP2.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Xu, 2011, Impaired expression of uncoupling protein 2 causes defective postischemic angiogenesis in mice deficient in AMP-activated protein kinase alpha subunits, Arterioscler. Thromb. Vasc. Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationMitophagy increased significantly in cardiomyocytes exposed to hypoxic conditions, which was accompanied by AMPK activation.
“Mitophagy increased significantly in cardiomyocytes exposed to hypoxic conditions, which was accompanied by AMPK activation [133].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [133] Zhang, 2018, AMPK activation serves a critical role in mitochondria quality control via modulating mitophagy in the heart under chronic hypoxia, Int. J. Mol. Med.
Not checked in the free run.
May combine two claims.
PremisecitationUnder chronic hypoxia, PGC1α is upregulated, resulting in a subsequent increase of mitochondrial biogenesis.
“Under chronic hypoxia, PGC1α is upregulated, resulting in a subsequent increase of mitochondrial biogenesis [175].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [175] Zhu, 2010, Hypoxia induces PGC-1alpha expression and mitochondrial biogenesis in the myocardium of TOF patients, Cell Res. source
Not checked in the free run.
May combine two claims.
PremisecitationTreatment of cardiomyocytes with carvedilol augmented phosphorylation of AMPK and its downstream substrate ACC, and ameliorated hypoxia-induced impairment.
“Treatment of cardiomyocytes with carvedilol augmented phosphorylation of AMPK and its downstream substrate ACC, and ameliorated hypoxia-induced impairment [182].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [182] Hu, 2019, The cardioprotective effects of carvedilol on ischemia and reperfusion injury by AMPK signaling pathway, Biomed. Pharmacother. source
Not checked in the free run.
May combine two claims.
PremisecitationAMPK decreased apoptosis, improved post-ischemic recovery, and limited myocardial infarction.
“Mechanically, AMPK increased glucose uptake and glucose transporter 4 translocation [171], decreased apoptosis, improved post-ischemic recovery, and limited myocardial infarction (MI) [172,173].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [172] Ma, 2010, Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart, Circulation source
Not checked in the free run.
- cites [173] Russell, 2004, AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury, J. Clin. Investig. source
Not checked in the free run.
May combine two claims.
PremisecitationWhen AMPK activation was blocked, mitophagy decreased as well, which subsequently gave rise to cardiomyocyte apoptosis.
“Consistently, when AMPK activation was blocked, mitophagy decreased as well, which subsequently gave rise to cardiomyocyte apoptosis [133].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [133] Zhang, 2018, AMPK activation serves a critical role in mitochondria quality control via modulating mitophagy in the heart under chronic hypoxia, Int. J. Mol. Med.
Not checked in the free run.
May combine two claims.
PremisecitationI/R injury causes myocardial damage and increases 30-day mortality rates.
“I/R injury causes myocardial damage and increases 30-day mortality rates [180].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [180] Abbate, 2008, No-reflow: The next challenge in treatment of ST-elevation acute myocardial infarction, Eur. Heart J. source
Not checked in the free run.
May combine two claims.
PremisecitationAMPK increased glucose uptake and glucose transporter 4 translocation.
“Mechanically, AMPK increased glucose uptake and glucose transporter 4 translocation [171], decreased apoptosis, improved post-ischemic recovery, and limited myocardial infarction (MI) [172,173].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [171] Miller, 2008, Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationI/R triggered a DRP1-dependent mitochondrial fragmentation, which subsequently led to oligomerization of voltage-dependent anion channel 1, liberation of hexokinase 2, opening of mitochondrial permeability transition pore, upregulation of PINK1-PARKIN signaling, and eventual mitophagy-mediated cell death.
“In vitro mechanism studies showed that I/R triggered a DRP1-dependent mitochondrial fragmentation, which subsequently led to oligomerization of voltage-dependent anion channel 1, liberation of hexokinase 2, opening of mitochondrial permeability transition pore, upregulation of PINK1–PARKIN signaling, and eventual mitophagy-mediated cell death [134].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [134] Zhou, 2017, Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis, J. Pineal. Res. source
Not checked in the free run.
May combine two claims.
PremisecitationMOTS-c is a bioactive mitochondrial-derived peptide shown to activate the AMPK pathway and modulate metabolic homeostasis.
“The mitochondrial open reading frame of the 12S rRNA-c (MOTS-c) is a bioactive mitochondrial-derived peptide shown to activate the AMPK pathway and modulate metabolic homeostasis [193].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [193] Lee, 2015, The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance, Cell Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationNitrite activated protein kinase A, which in turn suppressed DRP1-dependent mitochondrial fission, augmented ΔΨm, and promoted superoxide production.
“Further mechanism studies showed that nitrite activated protein kinase A, which in turn suppressed DRP1-dependent mitochondrial fission, augmented ΔΨm, and promoted superoxide production [135].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [135] Mo, 2014, Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion, Cardiovasc. Res. source
Not checked in the free run.
May combine two claims.
PremisecitationMelatonin promoted cell survival via AMPKα activation, accompanied by phosphor-DRP1-S616 reduction and phosphor-DRP1-S637 elevation, which normalized mitochondrial fission.
“Melatonin promoted cell survival via AMPKα activation, accompanied by phosphor-DRP1-S616 reduction and phosphor-DRP1-S637 elevation, which normalized mitochondrial fission [134].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [134] Zhou, 2017, Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis, J. Pineal. Res. source
Not checked in the free run.
May combine two claims.
PremisecitationMelatonin significantly decreased myocardial infarction, improved cardiac function, normalized blood flow, and lowered microcirculation perfusion impairment.
“Melatonin significantly decreased myocadiac infarction, improved cardiac function, normalized blood flow, and lowered microcirculation perfusion impairment [134].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [134] Zhou, 2017, Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis, J. Pineal. Res. source
Not checked in the free run.
May combine two claims.
PremisecitationAdministration of melatonin restored the endothelial barrier, promoted eNOS expression, decreased inflammatory cell infiltration, and lowered endothelial damage in cardiac microcirculation endothelial cells.
“Histological analysis revealed that administration of melatonin restored the endothelial barrier, promoted eNOS expression, decreased inflammatory cell infiltration, and lowered endothelial damage in cardiac microcirculation endothelial cells [134].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [134] Zhou, 2017, Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis, J. Pineal. Res. source
Not checked in the free run.
May combine two claims.
PremisecitationPhosphorylated AMPK increased and the expression of endothelin B and angiotensin II receptor type 1 receptors decreased after MOTS-c treatment.
“In parallel, phosphorylated AMPK increased and the expression of endothelin B (ETB) and angiotensin II receptor type 1 (AT1) receptors decreased after MOTS-c treatment [136].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [136] Wei, 2020, Mitochondrial-derived peptide MOTS-c attenuates vascular calcification and secondary myocardial remodeling via adenosine monophosphate-activated protein kinase signaling pathway, Cardiorenal. Med. source
Not checked in the free run.
May combine two claims.
InterpretationcitationTSPO regulates neointimal formation after vascular injury via stimulating VSMC proliferation and migration, which is likely dependent on AMPK suppression.
“These results indicate that TSPO regulates neointimal formation after vascular injury via stimulating VSMC proliferation and migration, which is likely dependent on AMPK suppression [137].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [137] Wu, 2020, TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation, Acta Pharmacol. Sin. source
Not checked in the free run.
May combine two claims.
PremisecitationNeointimal hyperplasia narrows the luminal diameter, leading to decreased blood flow and recurrence of anginal symptoms.
“Neointimal hyperplasia narrows the luminal diameter, leading to decreased blood flow and recurrence of anginal symptoms [196].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [196] Schwartz, 1997, Perspectives series: Cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis, J. Clin. Investig. source
Not checked in the free run.
May combine two claims.
PremisecitationPrevention of mitochondrial fission restored the interaction between voltage-dependent anion channel 1 and hexokinase 2, stopped mitochondrial permeability transition pore opening, and PINK1-PARKIN activation, ultimately blunting cell death.
“The prevention of mitochondrial fission further restored the interaction between voltage-dependent anion channel 1 and hexokinase 2, stopped mitochondrial permeability transition pore opening, and PINK1–PARKIN activation, ultimately blunting cell death [134].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [134] Zhou, 2017, Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis, J. Pineal. Res. source
Not checked in the free run.
May combine two claims.
PremisecitationLoss of AMPK activity is pro-hypertrophic because lines of molecular signaling pathways that control cell growth are attenuated by AMPK activation.
“The loss of AMPK activity is believed to be pro-hypertrophic because lines of molecular signaling pathways that control cell growth are attenuated by AMPK activation [197,198,199].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [197] Chan, 2008, Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt, J. Biol. Chem. source
Not checked in the free run.
- cites [198] Chan, 2004, Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte, J. Biol. Chem. source
Not checked in the free run.
- cites [199] Browne, 2004, Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398, J. Biol. Chem. source
Not checked in the free run.
May combine two claims.
PremisecitationROS scavenging blocks AMPK activation and blunts nitrite-induced cardioprotection after H/R.
“Moreover, ROS scavenging blocks AMPK activation and blunts nitrite-induced cardioprotection after H/R [135].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [135] Mo, 2014, Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion, Cardiovasc. Res. source
Not checked in the free run.
May combine two claims.
PremisecitationDRP1-S616 phosphorylation was decreased, while DRP1-S637 phosphorylation was increased, ultimately leading to mitochondrial fission.
“In the meantime, DRP1-S616 phosphorylation was decreased, while DRP1-S637 phosphorylation was increased, ultimately leading to mitochondrial fission [229].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [229] Zhou, 2018, Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission, Redox Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationSome pharmacological AMPK activators, such as MK-8722, cause cardiac hypertrophy, which is considered the main side effect of pharmacological pan-AMPK activation.
“However, some pharmacological AMPK activators, such as MK-8722 [203], cause cardiac hypertrophy, which is considered the main side effect of pharmacological pan-AMPK activation [17].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [203] Feng, 2018, Discovery of MK-8722: A systemic, direct pan-activator of amp-activated protein kinase, ACS Med. Chem. Lett. source
Not checked in the free run.
- cites [17] Myers, 2017, Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy, Science source
Not checked in the free run.
May combine two claims.
PremisecitationIn failing heart samples from patients or TAC mice, the isoform of AMPKα shifted from α2 to α1, which is associated with reduced mitophagy and dysfunctional mitochondria.
“In failing heart samples from patients or TAC mice, the isoform of AMPKα shifted from α2 to α1, which is associated with reduced mitophagy and dysfunctional mitochondria [117].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Wang, 2018, AMPKalpha2 protects against the development of heart failure by enhancing mitophagy via pink1 phosphorylation, Circ. Res. source
Not checked in the free run.
May combine two claims.
PremisecitationClusterin inhibits mitochondrial fragmentation while activating AMPK.
“Clusterin, which exerts beneficial effects in ECs under diabetic conditions (both type 1 and type 2), inhibits mitochondrial fragmentation while activating AMPK [228].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [228] Ren, 2019, Clusterin ameliorates endothelial dysfunction in diabetes by suppressing mitochondrial fragmentation, Free Radic. Biol. Med. source
Not checked in the free run.
May combine two claims.
PremisecitationSIRT5 ablation attenuated cardiac hypertrophy and cardiac dysfunction in the TAC model, which is accompanied by the reduction of ATP, increase of AMP-to-ATP ratio, and enhancement of AMPK activity.
“Consistently, SIRT5 ablation attenuated cardiac hypertrophy and cardiac dysfunction in the TAC model, which is accompanied by the reduction of ATP, increase of AMP-to-ATP ratio, and enhancement of AMPK activity [138].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [138] Zhang, M., Wu, J., Sun, R., Tao, X., Wang, X., Kang, Q., Wang, H., Zhang, L., Liu, P., and Zhang, J. (2019). SIRT5 deficiency suppresses mitochondrial ATP production and promotes AMPK activation in response to energy stress. PLoS ONE, 14. source
Not checked in the free run.
May combine two claims.
PremisecitationEndothelial dysfunction is attributed to many causes, including oxidative stress, chronic inflammation, and endothelium activation, in diabetes, which exhibits excessive free fatty acid, insulin resistance, and/or hyperglycemia.
“Endothelial dysfunction is attributed to many causes, including oxidative stress, chronic inflammation, and endothelium activation, in diabetes, which exhibits excessive free fatty acid (FFA), insulin resistance, and/or hyperglycemia [216,217].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [216] Zhang, 2012, The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: An update, Basic Res. Cardiol. source
Not checked in the free run.
- cites [217] Kim, 2006, Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationSIRT5 deficiency attenuated ATP production from mitochondrial ETC, increased the AMP-to-ATP ratio, and in turn activated AMPK in both cultured cells and hearts under the conditions of energy stress.
“SIRT5 deficiency attenuated ATP production from mitochondrial ETC, increased the AMP-to-ATP ratio, and in turn activated AMPK in both cultured cells and hearts under the conditions of energy stress [138].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [138] Zhang, M., Wu, J., Sun, R., Tao, X., Wang, X., Kang, Q., Wang, H., Zhang, L., Liu, P., and Zhang, J. (2019). SIRT5 deficiency suppresses mitochondrial ATP production and promotes AMPK activation in response to energy stress. PLoS ONE, 14. source
Not checked in the free run.
May combine two claims.
PremisecitationBoth the conditions of hyperlipidemia and hyperglycemia impair mitochondrial dynamics by shifting the balance to excessive mitochondrial fission, leading to mitochondrial ROS over production and ETC impairment.
“Both the conditions of hyperlipidemia and hyperglycemia impair mitochondrial dynamics by shifting the balance to excessive mitochondrial fission, leading to mitochondrial ROS over production and ETC impairment [221,222,223].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [221] LaRocca, 2014, Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice, J. Physiol. source
Not checked in the free run.
- cites [222] Huang, 2018, The uremic toxin hippurate promotes endothelial dysfunction via the activation of Drp1-mediated mitochondrial fission, Redox Biol. source
Not checked in the free run.
- cites [223] Yu, 2006, Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
May combine two claims.
InterpretationcitationSIRT5 controls cellular energy metabolism by AMPK activation upon energy stress, which further confirms the cardioprotective role of AMPK in left ventricular hypertrophy under the stress of pressure overload.
“Thus, this study unveils a crucial role of SIRT5 in controlling cellular energy metabolism by AMPK activation upon energy stress, which further confirms the cardioprotective role of AMPK in left ventricular hypertrophy under the stress of pressure overload [138].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [138] Zhang, M., Wu, J., Sun, R., Tao, X., Wang, X., Kang, Q., Wang, H., Zhang, L., Liu, P., and Zhang, J. (2019). SIRT5 deficiency suppresses mitochondrial ATP production and promotes AMPK activation in response to energy stress. PLoS ONE, 14. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMAMs play a vital role in lipid transport, Ca2+ signaling, cell survival, and energy metabolism, and have been implicated in diseases including Alzheimer's disease, cancer, lysosomal storage disease, diabetes mellitus, obesity, and metabolic disorders.
“MAMs play a vital role in lipid transport, Ca2+ signaling, cell survival, and energy metabolism [234], and have been implicated in diseases including Alzheimer’s disease [235], cancer [236], lysosomal storage disease [237], diabetes mellitus [238,239], obesity, and metabolic disorders [240].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [234] Rowland, 2012, Endoplasmic reticulum-mitochondria contacts: Function of the junction, Nat. Rev. Mol. Cell Biol. source
Not checked in the free run.
- cites [235] Suski, 2017, Localization and processing of the amyloid-beta protein precursor in mitochondria-associated membranes, J. Alzheimers Dis.
Not checked in the free run.
- cites [236] Ando, 2018, Remodeling of Ca(2+) signaling in cancer: Regulation of inositol 1,4,5-trisphosphate receptors through oncogenes and tumor suppressors, Adv. Biol. Regul. source
Not checked in the free run.
May combine two claims.
PremisecitationHigh glucose-driven inactivation of AMPK increased FUNDC1, resulting in aberrant MAM formation, mitochondrial Ca2+ increase, mitochondrial dysfunction, and cardiac dysfunction.
“High glucose-driven inactivation of AMPK increased FUNDC1, resulting in aberrant MAM formation, mitochondrial Ca2+ increase, mitochondrial dysfunction, and cardiac dysfunction [139].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [139] Wu, 2019, Hyperglycemia-Driven Inhibition of AMP-activated protein kinase alpha2 induces diabetic cardiomyopathy by promoting mitochondria-associated endoplasmic reticulum membranes in vivo, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationUpregulation of XO was accompanied by excessive ROS production, resulting in the Ser616 phosphorylation as well as the mitochondrial migration of DRP1.
“Upregulation of XO was accompanied by excessive ROS production, resulting in the Ser616 phosphorylation as well as the mitochondrial migration of DRP1 [140].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] Cui, 2018, Melatonin alleviates inflammation-induced apoptosis in human umbilical vein endothelial cells via suppression of Ca(2+)-XO-ROS-Drp1-mitochondrial fission axis by activation of AMPK/SERCA2a pathway, Cell Stress Chaperones source
Not checked in the free run.
May combine two claims.
PremisecitationVildagliptin improved mitochondrial dysfunction in diabetic endothelial cells, possibly by blunting DRP1-dependent mitochondrial fission by inducing AMPK activation.
“Vildagliptin improved mitochondrial dysfunction in diabetic ECs, possibly by blunting DRP1-dependent mitochondrial fission by inducing AMPK activation [230].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [230] Liu, 2019, Vildagliptin improves high glucose-induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission, J. Cell. Mol. Med. source
Not checked in the free run.
May combine two claims.
PremisecitationUnder diabetic conditions, endothelial cells often have reduced eNOS activity and diminished NO production.
“Thus, under diabetic conditions, ECs often have reduced eNOS activity and diminished NO production [259].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [259] Dresner, 1999, Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity, J. Clin. Investig. source
Not checked in the free run.
May combine two claims.
PremisecitationMelatonin activated AMPK, which was associated with the upregulation of sarcoplasmic/endoplasmic reticulum calcium ATPase 2a.
“Importantly, melatonin activated AMPK, which was associated with the upregulation of sarcoplasmic/endoplasmic reticulum calcium ATPase 2a [140].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] Cui, 2018, Melatonin alleviates inflammation-induced apoptosis in human umbilical vein endothelial cells via suppression of Ca(2+)-XO-ROS-Drp1-mitochondrial fission axis by activation of AMPK/SERCA2a pathway, Cell Stress Chaperones source
Not checked in the free run.
May combine two claims.
PremisecitationObesity-related type 2 diabetes patients often have elevated plasma FFAs, because of either increased amounts of FFAs released from large amounts of adipose tissue or impaired FFA clearance.
“Obesity-related type 2 diabetes patients often have elevated plasma FFAs, because of either increased amounts of FFAs released from large amounts of adipose tissue or impaired FFA clearance [258].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [258] Boden, 2003, Effects of free fatty acids (FFA) on glucose metabolism: Significance for insulin resistance and type 2 diabetes, Exp. Clin. Endocrinol. Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationMelatonin-activated AMPK-sarcoplasmic/endoplasmic reticulum calcium ATPase 2a axis prevented calcium overload, XO-dependent ROS overproduction, DRP1-mediated mitochondrial fission, and apoptosis in lipopolysaccharide-treated cells.
“Further, melatonin-activated AMPK-sarcoplasmic/endoplasmic reticulum calcium ATPase 2a axis prevented calcium overload, XO-dependent ROS overproduction, DRP1-mediated mitochondrial fission, and apoptosis in lipopolysaccharide-treated cells [140].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] Cui, 2018, Melatonin alleviates inflammation-induced apoptosis in human umbilical vein endothelial cells via suppression of Ca(2+)-XO-ROS-Drp1-mitochondrial fission axis by activation of AMPK/SERCA2a pathway, Cell Stress Chaperones source
Not checked in the free run.
May combine two claims.
PremisecitationLipopolysaccharide triggered cytosolic calcium overload, and in turn upregulated XO, whose activity is calcium-dependent.
“Lipopolysaccharide triggered cytosolic calcium overload, and in turn upregulated XO, whose activity is calcium-dependent [140].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] Cui, 2018, Melatonin alleviates inflammation-induced apoptosis in human umbilical vein endothelial cells via suppression of Ca(2+)-XO-ROS-Drp1-mitochondrial fission axis by activation of AMPK/SERCA2a pathway, Cell Stress Chaperones source
Not checked in the free run.
May combine two claims.
PremisecitationFUNDC1 is essential for maintaining the MAM structure and ensuring appropriate Ca2+ transfer from the sarcoplasmic reticulum to mitochondria in healthy hearts.
“Study showed that mitochondrial outer membrane protein FUN14 domain containing 1 (FUNDC1) is essential for maintaining the MAM structure and ensuring appropriate Ca2+ transfer from the sarcoplasmic reticulum (i.e., ER in myocytes) to mitochondria in healthy hearts [241].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [241] Wu, 2017, Binding of FUN14 domain containing 1 with inositol 1,4,5-trisphosphate receptor in mitochondria-associated endoplasmic reticulum membranes maintains mitochondrial dynamics and function in hearts in vivo, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationCorosolic acid activated AMPK in a LKB1-dependent manner, and AMPK silencing abrogated its inhibitory effect on DRP1 activation and mitochondrial fission.
“CRA activated AMPK in a LKB1-dependent manner, and AMPK silencing abrogated its inhibitory effect on DRP1 activation and mitochondrial fission [141].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [141] Li, 2016, Inhibition of mitochondrial fission and NOX2 expression prevent nlrp3 inflammasome activation in the endothelium: The role of corosolic acid action in the amelioration of endothelial dysfunction, Antioxid. Redox Signal. source
Not checked in the free run.
May combine two claims.
PremisecitationDRP1 knockdown attenuated PA-induced NOX2 activation, and knockdown of DRP1 or NOX2 suppressed PA-induced NLRP3 inflammatory effect and strengthened the inhibitory effects of corosolic acid.
“DRP1 knockdown attenuated PA-induced NOX2 activation, and knockdown of DRP1 or NOX2 suppressed PA-induced NACHT, LRR, and PYD domains-containing protein 3 inflammatory effect and, in the meantime, strengthened the inhibitory effects of CRA [141].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [141] Li, 2016, Inhibition of mitochondrial fission and NOX2 expression prevent nlrp3 inflammasome activation in the endothelium: The role of corosolic acid action in the amelioration of endothelial dysfunction, Antioxid. Redox Signal. source
Not checked in the free run.
May combine two claims.
PremisecitationObesity is closely associated with cardiac disorders, which is assumed to be a consequence of the adaption to an oversupply of high-fat substrates.
“Obesity is closely associated with cardiac disorders, which is assumed to be a consequence of the adaption to an oversupply of high-fat substrates [262,263].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [262] Harmancey, 2008, Adaptation and maladaptation of the heart in obesity, Hypertension source
Not checked in the free run.
- cites [263] Louwe, 2012, Gender-dependent effects of high-fat lard diet on cardiac function in C57Bl/6J mice, Appl. Physiol. Nutr. Metab. source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenAMPK activation plays protective roles across diverse cardiovascular diseases.
“It is well-accepted that AMPK activation plays protective roles across diverse CVDs.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationCorosolic acid prevented mitochondrial fission by regulating DRP1 phosphorylation at Ser637 in an AMPK-dependent manner, contributing to the blockage of NOX2-related oxidative stress and suppressing NLRP3 inflammasome in the endothelium.
“These data collectively demonstrated that CRA prevented mitochondrial fission by regulating DRP1 phosphorylation at Ser637 in an AMPK-dependent manner, contributing to the blockage of NOX2-related oxidative stress and suppressing NACHT, LRR, and PYD domains-containing protein 3 inflammasome in the endothelium [141].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [141] Li, 2016, Inhibition of mitochondrial fission and NOX2 expression prevent nlrp3 inflammasome activation in the endothelium: The role of corosolic acid action in the amelioration of endothelial dysfunction, Antioxid. Redox Signal. source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenStructural and functional changes to mitochondria may be amplified under disease conditions.
“Far beyond our current knowledge are the structural and functional changes to mitochondria that may be amplified under disease conditions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenAMPK has emerged as a guardian of mitochondria because almost all mitochondrial insults can activate AMPK.
“AMPK has emerged as a guardian of mitochondria because almost all mitochondrial insults can activate AMPK.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenThe interplay within the AMPK-mitochondrial axis during the initiation and progression of cardiovascular diseases is poorly investigated.
“However, the interplay within the AMPK–mitochondrial axis during the initiation and progression of CVDs is poorly investigated.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPomegranate extract activated AMPK, which may be responsible for the intervention of mitochondrial loss through promoting mitochondrial biogenesis and the attenuation of oxidative stress by means of upregulating phase II enzymes in HFD hearts.
“Concomitantly, pomegranate extract activated AMPK, which may be responsible for the intervention of mitochondrial loss through promoting mitochondrial biogenesis and the attenuation of oxidative stress by means of upregulating phase II enzymes in HFD hearts [142].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [142] Cao, 2015, Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation, Sci. Rep. source
Not checked in the free run.
May combine two claims.
PremisecitationA direct functional connection between AMPK signaling and β-adrenergic responsiveness exists in the heart, and AMPK might be a valuable target to recover the decreased β-adrenergic responsive in the heart of obesity.
“A direct functional connection between AMPK signaling and β-adrenergic responsiveness exists in the heart, and AMPK might be a valuable target to recover the decreased β-adrenergic responsive in the heart of obesity [270].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [270] Bussey, 2018, Cardiac beta-adrenergic responsiveness of obese Zucker rats: The role of AMPK, Exp. Physiol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenLimited evidence has focused on mitochondrial dynamics, mitochondrial biogenesis, and mitophagy, the three common functions of mitochondria that have been studied by cell biologists.
“Limited evidence has focused on mitochondrial dynamics, mitochondrial biogenesis, and mitophagy, the three common functions of mitochondria that have been studied by cell biologists.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPunicalagin protects against HFD-induced cardiac disorders by activating AMPK pathway and promoting mitochondrial biogenesis.
“Punicalagin, the major active component in pomegranate extract, protects against HFD-induced cardiac disorders by activating AMPK pathway and promoting mitochondrial biogenesis [142].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [142] Cao, 2015, Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation, Sci. Rep. source
Not checked in the free run.
May combine two claims.
PremisecitationThe loss of AMPK activity exacerbated cardiac hypertrophy and dysfunctional contractility of HFD-fed mice.
“The loss of AMPK activity exacerbated cardiac hypertrophy and dysfunctional contractility of HFD-fed mice [268].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [268] Turdi, 2011, Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction, J. Mol. Cell. Cardiol. source
Not checked in the free run.
May combine two claims.
PremisecitationC1q/tumor necrosis factor-related protein 9 exhibited anti-myocardial lipotoxicity effects and attenuated cardiac hypertrophy, likely via activation of the LKB1-AMPK signaling.
“C1q/tumor necrosis factor-related protein 9 exhibited anti-myocardial lipotoxicity effects and attenuated cardiac hypertrophy, likely via activation of the LKB1–AMPK signaling [269].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [269] Zuo, 2020, CTRP9 knockout exaggerates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy through inhibiting the LKB1/AMPK pathway, J. Cell. Mol. Med. source
Not checked in the free run.
May combine two claims.
PremisecitationIncreased body weight switches the substrate of the heart from fatty acid to sugar, resulting in fat accumulation around the heart and eventually inducing cardiac impairment and increasing the risk of MI.
“Increased body weight switches the substrate of the heart from fatty acid to sugar, resulting in fat accumulation around the heart and eventually inducing cardiac impairment and increasing the risk of MI [264,265].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [264] Schram, 2008, Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure, Trends Cardiovasc. Med. source
Not checked in the free run.
- cites [265] Look, 2009, Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: A new link between obesity and heart disease, Circ. Res. source
Not checked in the free run.
The paper relies on this without support.
Mitochondria are the primary source of ATP production in the cell.
“Mitochondria are considered the primary source of ATP production in the cell.”
The paper relies on this without support.
Mitochondrial dysfunction occurs in the development of many cardiovascular diseases owing to production of ROS beyond control.
“Mitochondrial dysfunction occurs in the development of many CVDs such as atherosclerosis, ischemia-reperfusion (I/R) injury, hypertension, diabetes, cardiac hypertrophy, and heart failure (HF), owing to the production of ROS beyond control.”
The paper relies on this without support.
AMPK is widely expressed in the cardiovascular system.
“AMPK is widely expressed in the cardiovascular system.”
The paper relies on this without support.
The α1 isoform predominates in VSMCs, ECs, adipocytes, and monocytes/macrophages, whereas cardiomyocytes express much higher amounts of the α2 isoform.
“The α1 isoform predominates in VSMCs, ECs, adipocytes, and monocytes/macrophages, whereas cardiomyocytes express much higher amounts of the α2 isoform.”
The paper relies on this without support.
Aberrant AMPK signaling is involved in the pathogenesis of various cardiovascular diseases, including hypertension, atherosclerosis, and stroke.
“Moreover, aberrant AMPK signaling is involved in the pathogenesis of various CVDs, including hypertension, atherosclerosis, and stroke.”
The paper relies on this without support.
Oxidative stress caused by risk factors represents a major contributor to endothelial dysfunction as a common predisposing condition to atherosclerosis.
“Oxidative stress caused by risk factors represents a major contributor to endothelial dysfunction as a common predisposing condition to atherosclerosis.”
The paper relies on this without support.
UCP2 appears to have a main function of controlling ROS generation in diabetes, obesity, and atherosclerosis.
“It appears that UCP2 has a main function of controlling ROS generation in diabetes, obesity, and atherosclerosis, although it was originally considered as a modulator of nonshivering thermogenesis.”
The paper relies on this without support.
Rapid Ca2+ influx into mitochondrial matrix occurs through the mitochondrial Ca2+ uniporter, a specific channel located at the inner mitochondrial membrane.
“It is well established that rapid Ca2+ influx into mitochondrial matrix occurs through the mitochondrial Ca2+ uniporter (MCU), a specific channel located at the inner mitochondrial membrane.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AMPK activators such as metformin and berberine improve mitochondrial efficiency and energy substrate utilization, which can reduce fatigue and increase endurance capacity.
“For example, AMPK activators such as metformin and berberine improve mitochondrial efficiency and energy substrate utilization, which can reduce fatigue and increase endurance capacity”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [106]
Section 3.1 identifies metformin and berberine as agents that induce AMPK activation, and section 4.1 describes AMPK’s role in mitochondrial biogenesis. The paper does not establish that these two drugs improve mitochondrial efficiency or energy-substrate utilization, or that they reduce fatigue or increase endurance capacity. Pages are not specified in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measuredMetformin and berberine activate AMPK, promoting fatty acid oxidation, mitochondrial biogenesis, and improved insulin sensitivity.
“For example, metformin and berberine activate AMPK, promoting fatty acid oxidation, mitochondrial biogenesis, and improved insulin sensitivity”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [106]
Section 3.2 reports that both drugs activate AMPK and that berberine improves insulin sensitivity in type 2 diabetes models. Section 2.2 links metformin-induced AMPK activation to mitochondrial biogenesis, and section 4.1 describes AMPK as a promoter of mitochondrial biogenesis generally. Our copy does not establish that both drugs promote fatty acid oxidation or that berberine promotes mitochondrial biogenesis through AMPK. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Empagliflozin is said both to inhibit and to cause mitochondrial fission
MinorThe passage attributes empagliflozin's protective effect to inhibition of mitochondrial fission, but then says its associated phosphorylation changes ultimately lead to mitochondrial fission.
“Empagliflozin exerted its protective roles via inhibition of AMPK-dependent mitochondrial fission [229].”
“In the meantime, DRP1-S616 phosphorylation was decreased, while DRP1-S637 phosphorylation was increased, ultimately leading to mitochondrial fission [229].”
Melatonin is said both to prevent and to induce endothelial apoptosis
MinorThe paragraph first says melatonin protects endothelial cells against inflammation-mediated apoptosis, but its concluding sentence says melatonin induces that apoptosis.
“For instance, melatonin protected HUVECs against lipopolysaccharide-mediated apoptosis [140].”
“Collectively, this study demonstrated that melatonin induced endothelial cell apoptosis through activation of the AMPK-sarcoplasmic/endoplasmic reticulum calcium ATPase 2a pathway under conditions of inflammation [140].”
MFF phosphorylation site differs between adjacent statements
MinorOne statement identifies Ser155 and Ser173 as the two MFF sites phosphorylated by AMPK; the next identifies Ser155 and Ser172. The second site is inconsistent.
“In human bone osteosarcoma epithelial cells (U2OS) and MEFs, AMPK directly phosphorylated MFF on two sites, Ser155 and Ser173 [82,104].”
“A further study showed that AMPK-driven MFF phosphorylation at Ser155 and Ser172 is one potential mechanism to account for mitochondrial fission owing to mitochondrial respiration decline [82].”
Cites
5 retracted
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 471 · see citing works
Self-citationRetractedXie, Z., Zhang, J., Wu, J., Viollet, B., & Zou, M. (2008) · Diabetes · doi:10.2337/db08-0610 · Cited by 163 · see citing works
Self-citationRetractedZhang, J., Xie, Z., Dong, Y., Wang, S., Liu, C., & Zou, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802578200 · Cited by 118 · see citing works
Self-citationRetractedRETRACTED: Redox Regulation of the AMP-Activated Protein Kinase
Han, Y., Wang, Q., Song, P., Zhu, Y., & Zou, M.-H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015420 · Cited by 71 · see citing works
Self-citationRetractedZou, M.-H., Hou, X., Shi, C., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.w119.011600 · Cited by 2 · see citing works
Self-citationRetractedJames, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867 · see citing works
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220 · see citing works
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · see citing works
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · see citing works
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602 · see citing works
Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311 · see citing works
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914 · see citing works
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849 · see citing works
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in <i>PINK1</i>
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · see citing works
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · see citing works
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890 · see citing works
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739 · see citing works
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600 · see citing works
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546 · see citing works
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513 · see citing works
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491 · see citing works
The mechanisms of action of metformin
Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287 · see citing works
Oxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055 · see citing works
AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
Garcia, D., & Shaw, R. J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.032 · Cited by 1,994 · see citing works
Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter
Baughman, J. M., Perocchi, F., Girgis, H. S., Plovanich, M. E., Belcher-Timme, C. A., Sancak, Y., Bao, X., Strittmatter, L., Goldberger, O., Bogorad, R., et al. (2011) · Nature · doi:10.1038/nature10234 · Cited by 1,926 · see citing works
The “no-reflow” phenomenon after temporary coronary occlusion in the dog
Kloner, R. A., Ganote, C. E., & Jennings, R. B. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107898 · Cited by 1,842 · see citing works
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,838 · see citing works
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797 · see citing works
Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Mäkelä, T. P., Alessi, D. R., & Hardie, D. G. (2003) · Journal of Biology · doi:10.1186/1475-4924-2-28 · Cited by 1,666 · see citing works
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652 · see citing works
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650 · see citing works
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,633 · see citing works
Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589 · see citing works
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577 · see citing works
A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter
Stefani, D. D., Raffaello, A., Teardo, E., Szabò, I., & Rizzuto, R. (2011) · Nature · doi:10.1038/nature10230 · Cited by 1,431 · see citing works
Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · see citing works
Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network
Scarpulla, R. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.09.019 · Cited by 1,281 · see citing works
Yu, T., Robotham, J. L., & Yoon, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511154103 · Cited by 1,246 · see citing works
AMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222 · see citing works
Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure
Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., et al. (2012) · Nature · doi:10.1038/nature10992 · Cited by 1,201 · see citing works
AMP-activated protein kinase mediates mitochondrial fission in response to energy stress
Toyama, E. Q., Herzig, S., Courchet, J., Lewis, T. L., Losón, O. C., Hellberg, K., Young, N. P., Chen, H., Polleux, F., Chan, D. C., et al. (2016) · Science · doi:10.1126/science.aab4138 · Cited by 1,085 · see citing works
Arsenijevic, D., Onuma, H., Pecqueur, C., Raimbault, S., Manning, B. S., Miroux, B., Couplan, E., Alves‐Guerra, M., Goubern, M., Surwit, R. S., et al. (2000) · Nature Genetics · doi:10.1038/82565 · Cited by 1,079 · see citing works
Marui, N., Offermann, M. K., Swerlick, R., Kunsch, C., Rosen, C. A., Ahmad, M., Alexander, R. W., & Medford, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116778 · Cited by 1,072 · see citing works
Brand, M. D. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.001 · Cited by 1,063 · see citing works
Zong, H., Ren, J. M., Young, L. H., Pypaert, M., Mu, J., Birnbaum, M. J., & Shulman, G. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252625599 · Cited by 1,036 · see citing works
Endoplasmic reticulum-mitochondria contacts: Function of the junction
Rowland, A. A., & Voeltz, G. K. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3440 · Cited by 1,018 · see citing works
Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells
Chen, H., Montagnani, M., Funahashi, T., Shimomura, I., & Quon, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307878200 · Cited by 993 · see citing works
Structure of mammalian AMPK and its regulation by ADP
Xiao, B., Sanders, M. J., Underwood, E., Heath, R., Mayer, F. V., Carmena, D., Jing, C., Walker, P. A., Eccleston, J. F., Haire, L. F., et al. (2011) · Nature · doi:10.1038/nature09932 · Cited by 926 · see citing works
Salminen, A., Hyttinen, J. M. T., & Kaarniranta, K. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0748-0 · Cited by 866 · see citing works
Reactive oxygen species in health and disease
Alfadda, A. A., & Sallam, R. M. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/936486 · Cited by 824 · see citing works
Greer, E. L., Oskoui, P. R., Banko, M. R., Maniar, J. M., Gygi, M. P., Gygi, S. P., & Brunet, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705325200 · Cited by 820 · see citing works
Marsin, A.-S., Bertrand, L., Rider, M. H., Deprez, J., Beauloye, C., Vincent, M. F., den Berghe, G. V., Carling, D., & Hue, L. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00742-9 · Cited by 818 · see citing works
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. M. F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 796 · see citing works
SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle
Nakagawa, T., Lomb, D. J., Haigis, M. C., & Guarente, L. (2009) · Cell · doi:10.1016/j.cell.2009.02.026 · Cited by 787 · see citing works
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Hawley, S. A., Ross, F. A., Chevtzoff, C., Green, K. A., Evans, A., Fogarty, S., Towler, M. C., Brown, L. J., Ogunbayo, O. A., Evans, A. M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.001 · Cited by 773 · see citing works
Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., & Walsh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310389200 · Cited by 759 · see citing works
A role for uncoupling protein‐2 as a regulator of mitochondrial hydrogen peroxide generation
Nègre‐Salvayre, A., Hirtz, C., Carrera, G., Cazenave, R., Troly, M., Salvayre, R., Pénicaud, L., & Casteilla, L. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.10.9271366 · Cited by 757 · see citing works
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748 · see citing works
Russell, R. R., Li, J., Coven, D. L., Pypaert, M., Zechner, C., Palmeri, M., Giordano, F. J., Mu, J., Birnbaum, M. J., & Young, L. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19297 · Cited by 738 · see citing works
Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes
Kolb, H., & Martin, S. (2017) · BMC Medicine · doi:10.1186/s12916-017-0901-x · Cited by 735 · see citing works
Arruda, A. P., Pers, B. M., Parlakgül, G., Güney, E., Inouye, K., & Hotamışlıgil, G. S. (2014) · Nature Medicine · doi:10.1038/nm.3735 · Cited by 722 · see citing works
Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J., Kim, S.-J., Mehta, H., Hevener, A. L., de Cabo, R., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.009 · Cited by 715 · see citing works
The macrophage foam cell as a target for therapeutic intervention
Li, A. C., & Glass, C. K. (2002) · Nature Medicine · doi:10.1038/nm1102-1235 · Cited by 700 · see citing works
Hawley, S. A., Gadalla, A. E., Olsen, G. S., & Hardie, D. G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2420 · Cited by 696 · see citing works
Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver
Duranski, M. R., Greer, J. J. M., Dejam, A., Jaganmohan, S., Hogg, N., Langston, W., Patel, R. P., Yet, S.-F., Wang, X., Kevil, C. G., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22493 · Cited by 674 · see citing works
Mitochondrial Complex III ROS Regulate Adipocyte Differentiation
Tormos, K. V., Ansó, E., Hamanaka, R. B., Eisenbart, J. D., Joseph, J., Kalyanaraman, B., & Chandel, N. S. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.007 · Cited by 662 · see citing works
Mammalian AMP-activated protein kinase subfamily
Stapleton, D., Mitchelhill, K. I., Gao, G., Widmer, J., Michell, B. J., Teh, T., House, C. M., Fernandez, C. S., Cox, T., Witters, L. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.611 · Cited by 652 · see citing works
Pan, X., Liu, J., Nguyen, T. T. M., Liu, C., Sun, J., Teng, Y., Fergusson, M. M., Rovira, I. I., Allen, M. D., Springer, D., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2868 · Cited by 645 · see citing works
Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding
CHEUNG, P. C. F., SALT, I. P., DAVIES, S. P., HARDIE, D. G., & CARLING, D. (2000) · Biochemical Journal · doi:10.1042/bj3460659 · Cited by 637 · see citing works
PINK1- and Parkin-mediated mitophagy at a glance
Jin, S. M., & Youle, R. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.093849 · Cited by 631 · see citing works
Shen, H.-M., & Liu, Z.-G. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.056 · Cited by 629 · see citing works
Webb, A., Bond, R., McLean, P., Uppal, R., Benjamin, N., & Ahluwalia, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402927101 · Cited by 608 · see citing works
Carling, D., Zammit, V. A., & Hardie, D. G. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80292-2 · Cited by 599 · see citing works
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)01368-7 · Cited by 595 · cited 1× · see citing works
“Activation loop phosphorylation increases AMPK activity by about 100-fold, while allosteric regulation changes AMPK activity up to tenfold in mammalian cells and about twofold in recombinant, bacterially produced AMPK [26,28,38,39].”
BackgroundStructural basis for AMP binding to mammalian AMP-activated protein kinase
Xiao, B., Heath, R., Saiu, P., Leiper, F. C., Leone, P., Jing, C., Walker, P. A., Haire, L., Eccleston, J. F., Davis, C. T., et al. (2007) · Nature · doi:10.1038/nature06161 · Cited by 591 · see citing works
Endogenous Drp1 Mediates Mitochondrial Autophagy and Protects the Heart Against Energy Stress
Ikeda, Y., Shirakabe, A., Maejima, Y., Zhai, P., Sciarretta, S., Toli, J., Nomura, M., Mihara, K., Egashira, K., Ohishi, M., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.303356 · Cited by 571 · see citing works
Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis
Bergeron, R., Ren, J. M., Cadman, K. S., Moore, I. K., Perret, P., Pypaert, M., Young, L. H., Semenkovich, C. F., & Shulman, G. I. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1340 · Cited by 561 · see citing works
Nitric oxide, cell bioenergetics and neurodegeneration
Moncada, S., & Bolaños, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03988.x · Cited by 556 · see citing works
Zhou, H., Wang, S., Zhu, P., Hu, S., Chen, Y., & Ren, J. (2018) · Redox Biology · doi:10.1016/j.redox.2017.12.019 · Cited by 550 · see citing works
Rabinovitch, R. C., Samborska, B., Faubert, B., Ma, E. H., Gravel, S.-P., Andrzejewski, S., Raissi, T. C., Pause, A., St.-Pierre, J., & Jones, R. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.026 · Cited by 543 · see citing works
Betz, C., Stracka, D., Prescianotto-Baschong, C., Frieden, M., Demaurex, N., & Hall, M. N. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302455110 · Cited by 538 · see citing works
Turner, N., Li, J.-Y., Gosby, A., To, S. W. C., Cheng, Z., Miyoshi, H., Taketo, M. M., Cooney, G. J., Kraegen, E. W., James, D. E., et al. (2008) · Diabetes · doi:10.2337/db07-1552 · Cited by 535 · see citing works
Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5
Schlicker, C., Gertz, M., Papatheodorou, P., Kachholz, B., Becker, C. F. W., & Steegborn, C. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.048 · Cited by 531 · see citing works
Gowans, G. J., Hawley, S. A., Ross, F. A., & Hardie, D. G. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.019 · Cited by 531 · see citing works
The endoplasmic reticulum–mitochondria connection: One touch, multiple functions
Marchi, S., Patergnani, S., & Pinton, P. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.10.015 · Cited by 506 · see citing works
Kukidome, D., Nishikawa, T., Sonoda, K., Imoto, K., Fujisawa, K., Yano, M., Motoshima, H., Taguchi, T., Matsumura, T., & Araki, E. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0943 · Cited by 504 · see citing works
Tong, M., Saito, T., Zhai, P., Oka, S.-I., Mizushima, W., Nakamura, M., Ikeda, S., Shirakabe, A., & Sadoshima, J. (2019) · Circulation Research · doi:10.1161/circresaha.118.314607 · Cited by 498 · see citing works
Xie, Z., Lau, K., Eby, B., Lozano, P., He, C., Pennington, B., Li, H., Rathi, S., Dong, Y., Tian, R., et al. (2011) · Diabetes · doi:10.2337/db10-0351 · Cited by 490 · see citing works
Self-citationPrevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes
Green, K., Brand, M. D., & Murphy, M. P. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s110 · Cited by 490 · see citing works
Hattori, Y., Suzuki, K., Hattori, S., & Kasai, K. (2006) · Hypertension · doi:10.1161/01.hyp.0000221429.94591.72 · Cited by 487 · see citing works
Ndrepepa, G., Tiroch, K., Fusaro, M., Keta, D., Seyfarth, M., Byrne, R. A., Pache, J., Alger, P., Mehilli, J., Schömig, A., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.054 · Cited by 475 · see citing works
Molecular targets of oxidative stress
Avery, S. V. (2011) · Biochemical Journal · doi:10.1042/bj20101695 · Cited by 474 · see citing works
Davis, B. J., Xie, Z., Viollet, B., & Zou, M. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1064 · Cited by 467 · see citing works
Self-citationAMP-activated Protein Kinase and the Regulation of Autophagic Proteolysis
Meley, D., Bauvy, C., Houben-Weerts, J. H. P. M., Dubbelhuis, P. F., Helmond, M. T. J., Codogno, P., & Meijer, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605488200 · Cited by 461 · see citing works
AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
Hardie, D. G. (2013) · Diabetes · doi:10.2337/db13-0368 · Cited by 458 · see citing works
Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase
Zmijewski, J. W., Banerjee, S., Bae, H., Friggeri, A., Lazarowski, E. R., & Abraham, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143685 · Cited by 441 · see citing works
Anderson, E. J., Kypson, A. P., Rodriguez, E., Anderson, C. A., Lehr, E. J., & Neufer, P. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.031 · Cited by 440 · see citing works
Arteriogenesis versus angiogenesis: similarities and differences
Heil, M., Eitenmüller, I. K., Schmitz‐Rixen, T., & Schaper, W. K. A. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00290.x · Cited by 434 · see citing works
Miller, E. J., Li, J., Leng, L., McDonald, C., Atsumi, T., Bucala, R., & Young, L. H. (2008) · Nature · doi:10.1038/nature06504 · Cited by 429 · see citing works
Enjoy the Trip: Calcium in Mitochondria Back and Forth
Stefani, D. D., Rizzuto, R., & Pozzan, T. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034216 · Cited by 424 · see citing works
Calvert, J. W., Gundewar, S., Jha, S., Greer, J. J. M., Bestermann, W. H., Tian, R., & Lefer, D. J. (2008) · Diabetes · doi:10.2337/db07-1098 · Cited by 422 · see citing works
Czubryt, M. P., McAnally, J., Fishman, G. I., & Olson, E. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337639100 · Cited by 418 · see citing works
Tubbs, E., Theurey, P., Vial, G., Bendridi, N., Bravard, A., Chauvin, M.-A., Ji-Cao, J., Zoulim, F., Bartosch, B., Ovize, M., et al. (2014) · Diabetes · doi:10.2337/db13-1751 · Cited by 411 · cited 1× · see citing works
“MAMs play a vital role in lipid transport, Ca2+ signaling, cell survival, and energy metabolism [234], and have been implicated in diseases including Alzheimer’s disease [235], cancer [236], lysosomal storage disease [237], diabetes mellitus [238,239], obesity, and metabolic disorders [240].”
BackgroundO'Neill, H. M., Maarbjerg, S. J., Crane, J. D., Jeppesen, J., Jørgensen, S. B., Schertzer, J. D., Shyroka, O., Kiens, B., van Denderen, B. J., Tarnopolsky, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105062108 · Cited by 406 · see citing works
Mungai, P. T., Waypa, G. B., Jairaman, A., Prakriya, M., Dokic, D., Ball, M. K., & Schumacker, P. T. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05124-11 · Cited by 385 · see citing works
Pathogenesis of atherosclerosis: A multifactorial process.
Singh, R. B., Mengi, S. A., Xu, Y., Arneja, A. S., & Dhalla, N. S. (2002) · PubMed Central · Cited by 381 · see citing works
<scp>AMP</scp> ‐activated protein kinase: a cellular energy sensor that comes in 12 flavours
Ross, F. A., MacKintosh, C., & Hardie, D. G. (2016) · The FEBS Journal · doi:10.1111/febs.13698 · Cited by 381 · see citing works
Zhou, H., Zhang, Y., Hu, S., Shi, C., Zhu, P., Ma, Q., Jin, Q., Cao, F., Tian, F., & Chen, Y. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12413 · Cited by 378 · see citing works
Structural and functional link between the mitochondrial network and the endoplasmic reticulum
Giorgi, C., Stefani, D. D., Bononi, A., Rizzuto, R., & Pinton, P. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.04.010 · Cited by 375 · see citing works
Obesity: Genetic, molecular, and environmental aspects
Barness, L. A., Opitz, J. M., & Gilbert‐Barness, E. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32035 · Cited by 373 · see citing works
AMP-Activated Protein Kinase: A Target for Drugs both Ancient and Modern
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.019 · Cited by 373 · see citing works
The role of AMP‐activated protein kinase in mitochondrial biogenesis
Reznick, R. M., & Shulman, G. I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.109512 · Cited by 371 · see citing works
Wang, Q., Zhang, M., Torres, G., Wu, S., Ouyang, C., Xie, Z., & Zou, M.-H. (2017) · Diabetes · doi:10.2337/db16-0915 · Cited by 370 · see citing works
The molecular era of the mitochondrial calcium uniporter
Kamer, K. J., & Mootha, V. K. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4039 · Cited by 367 · see citing works
Nutrient Sensing, Metabolism, and Cell Growth Control
Yuan, H.-X., Xiong, Y., & Guan, K. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.019 · Cited by 357 · see citing works
Browne, G. J., Finn, S. G., & Proud, C. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309773200 · Cited by 353 · see citing works
Boden, G. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-39781 · Cited by 348 · cited 1× · see citing works
“Obesity‐related type 2 diabetes patients often have elevated plasma FFAs, because of either increased amounts of FFAs released from large amounts of adipose tissue or impaired FFA clearance [258].”
BackgroundSanders, M. J., Ali, Z. S., Hegarty, B. D., Heath, R., Snowden, M. A., & Carling, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706543200 · Cited by 347 · see citing works
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy
Myers, R. W., Guan, H.-P., Ehrhart, J., Petrov, A., Prahalada, S., Tozzo, E., Yang, X., Kurtz, M. M., Trujillo, M., Gonzalez Trotter, D., et al. (2017) · Science · doi:10.1126/science.aah5582 · Cited by 346 · see citing works
Galić, S., Fullerton, M. D., Schertzer, J. D., Sikkema, S. R., Marcinko, K., Walkley, C. R., Izon, D. J., Honeyman, J. E., Chen, Z., van Denderen, B. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58577 · Cited by 344 · see citing works
Repairing mitochondrial dysfunction in disease
Sorrentino, V., Menzies, K. J., & Auwerx, J. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104908 · Cited by 337 · see citing works
Wang, B., Nie, J., Wu, L., Hu, Y., Wen, Z., Dong, L., Zou, M.-H., Chen, C., & Wang, D. W. (2018) · Circulation Research · doi:10.1161/circresaha.117.312317 · Cited by 334 · see citing works
Self-citationPharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke
McCullough, L. D., Zeng, Z., Li, H., Landree, L. E., McFadden, J., & Ronnett, G. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409985200 · Cited by 333 · see citing works
Hudson, E. R., Pan, D. A., James, J., Lucocq, J. M., Hawley, S. A., Green, K. A., Baba, O., Terashima, T., & Hardie, D. G. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00249-5 · Cited by 332 · see citing works
Nagata, D., Mogi, M., & Walsh, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300643200 · Cited by 331 · see citing works
Chan, A. Y. M., Soltys, C.-L. M., Young, M. E., Proud, C. G., & Dyck, J. R. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403528200 · Cited by 331 · see citing works
Emerling, B. M., Weinberg, F., Snyder, C., Burgess, Z., Mutlu, G. M., Viollet, B., Budinger, G. R. S., & Chandel, N. S. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.019 · Cited by 330 · see citing works
Mottillo, E. P., Desjardins, E. M., Crane, J. D., Smith, B. K., Green, A. E., Ducommun, S., Henriksen, T. I., Rebalka, I. A., Razi, A., Sakamoto, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.006 · Cited by 323 · see citing works
Wu, S., Lu, Q., Wang, Q., Ding, Y., Ma, Z., Mao, X., Huang, K., Xie, Z., & Zou, M.-H. (2017) · Circulation · doi:10.1161/circulationaha.117.030235 · Cited by 320 · see citing works
Self-citationAMPK: Lessons from transgenic and knockout animals
Viollet, B. (2009) · Frontiers in bioscience · doi:10.2741/3229 · Cited by 314 · see citing works
MUNDAY, M. R., CAMPBELL, D. G., CARLING, D., & HARDIE, D. G. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14201.x · Cited by 308 · see citing works
Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly
Hinchy, E. C., Gruszczyk, A. V., Willows, R., Navaratnam, N., Hall, A. R., Bates, G., Bright, T. P., Krieg, T., Carling, D., & Murphy, M. P. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002579 · Cited by 302 · see citing works
Wang, Z., Wilson, W. A., Fujino, M., & Roach, P. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5742-5752.2001 · Cited by 300 · see citing works
Wu, S., Lu, Q., Ding, Y., Wu, Y., Qiu, Y., Wang, P., Mao, X., Huang, K., Xie, Z., & Zou, M.-H. (2019) · Circulation · doi:10.1161/circulationaha.118.033552 · Cited by 298 · see citing works
Wang, S., Zhang, M., Liang, B., Xu, J., Xie, Z., Liu, C., Viollet, B., Yan, D., & Zou, M.-H. (2010) · Circulation Research · doi:10.1161/circresaha.109.212530 · Cited by 296 · see citing works
Schaper, J., Meiser, E., & Stämmler, G. (1985) · Circulation Research · doi:10.1161/01.res.56.3.377 · Cited by 296 · see citing works
The Regulation of AMP-Activated Protein Kinase by H2O2
Choi, S.-L., Kim, S.-J., Lee, K.-T., Kim, J., Mu, J., Birnbaum, M. J., Soo Kim, S., & Ha, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5544 · Cited by 294 · see citing works
The Ins and Outs of Mitochondrial Calcium
Finkel, T., Menazza, S., Holmström, K. M., Parks, R. J., Liu, J. C., Sun, J., Liu, J., Pan, X., & Murphy, E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305484 · Cited by 289 · see citing works
AMP-activated protein kinase regulation and biological actions in the heart
Zaha, V. G., & Young, L. H. (2012) · Circulation Research · doi:10.1161/circresaha.111.255505 · Cited by 279 · see citing works
NADPH oxidase and endothelial cell function
Ray, R., & Shah, A. M. (2005) · Clinical Science · doi:10.1042/cs20050067 · Cited by 278 · see citing works
Protein oxidation and cellular homeostasis: Emphasis on metabolism
Cecarini, V., Gee, J., Fioretti, E., Amici, M., Angeletti, M., Eleuteri, A. M., & Keller, J. N. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.039 · Cited by 274 · see citing works
Cokorinos, E., Delmore, J. E., Reyes, A. R., Albuquerque, B., Kjøbsted, R., Eskesen, N. O., Tran, J.-L., Jatkar, A., Cialdea, K., Esquejo, R. M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.010 · Cited by 267 · see citing works
AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633
Chen, Z., Peng, I.-C., Sun, W., Su, M.-I., Hsu, P.-H., Fu, Y., Zhu, Y., DeFea, K., Pan, S., Tsai, M.-D., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.187567 · Cited by 264 · cited 1× · see citing works
“In response to several stimuli, including metformin [156], adiponectin [157], thrombin [158], histamine [159], berberine [160], ciglitazone [161], and vascular endothelial growth factor [162], AMPK is activated and in turn acts as a direct activator of eNOS by phosphorylating its Ser1177 residue [163].”
BackgroundGioscia‐Ryan, R. A., LaRocca, T. J., Sindler, A. L., Zigler, M. C., Murphy, M. P., & Seals, D. R. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.268680 · Cited by 263 · see citing works
Endothelial dysfunction in obesity
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_15 · Cited by 255 · see citing works
Structure and Physiological Regulation of AMPK
Yan, Y., Zhou, X. E., Xu, H. E., & Melcher, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113534 · Cited by 254 · see citing works
Jung, K.-H., Chu, K., Ko, S.-Y., Lee, S.-T., Sinn, D.-I., Park, D.-K., Kim, J.-M., Song, E.-C., Kim, M., & Roh, J.-K. (2006) · Stroke · doi:10.1161/01.str.0000245116.40163.1c · Cited by 253 · see citing works
AMPK Activation of Muscle Autophagy Prevents Fasting-Induced Hypoglycemia and Myopathy during Aging
Bujak, A. L., Crane, J. D., Lally, J., Ford, R. J., Kang, S. J., Rebalka, I. A., Green, A. E., Kemp, B. E., Hawke, T. J., Schertzer, J. D., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.016 · Cited by 252 · see citing works
Shao, D., Oka, S.-I., Liu, T., Zhai, P., Ago, T., Sciarretta, S., Li, H., & Sadoshima, J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.013 · Cited by 252 · see citing works
Pathogenesis of Atherosclerosis: A Multifactorial Process
Buja, L. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-25879-4_2 · Cited by 252 · see citing works
Mitochondrial quality control: An integrated network of pathways
Fischer, F., Hamann, A., & Osiewacz, H. D. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.02.004 · Cited by 248 · see citing works
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt
Chan, A. Y. M., Dolinsky, V. W., Soltys, C.-L. M., Viollet, B., Baksh, S., Light, P. E., & Dyck, J. R. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802869200 · Cited by 244 · see citing works
NAD(P)H Oxidase–Dependent Self-Propagation of Hydrogen Peroxide and Vascular Disease
Cai, H. “. (2005) · Circulation Research · doi:10.1161/01.res.0000163631.07205.fb · Cited by 241 · see citing works
Thornton, C., Snowden, M. A., & Carling, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12443 · Cited by 240 · see citing works
Mancini, S. J., Boyd, D., Katwan, O. J., Strembitska, A., Almabrouk, T. A., Kennedy, S., Palmer, T. M., & Salt, I. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-23420-4 · Cited by 240 · see citing works
Protective Role of Uncoupling Protein 2 in Atherosclerosis
Blanc, J., Alves‐Guerra, M., Esposito, B., Rousset, S., Gourdy, P., Ricquier, D., Tedgui, A., Miroux, B., & Mallat, Z. (2003) · Circulation · doi:10.1161/01.cir.0000051722.66074.60 · Cited by 239 · see citing works
AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity.
Lantier, L., Fentz, J., Mounier, R., Leclerc, J., Treebak, J. T., Pehmøller, C., Sanz, N., Sakakibara, I., Saint‐Amand, E., Rimbaud, S., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-250449 · Cited by 228 · see citing works
Tripatara, P., Patel, N. S. A., Webb, A., Rathod, K., Lecomte, F. M. J., Mazzon, E., Cuzzocrea, S., Yaqoob, M. M., Ahluwalia, A., & Thiemermann, C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050450 · Cited by 226 · see citing works
Nitric oxide bioavailability dysfunction involves in atherosclerosis
Chen, J.-Y., Ye, Z.-X., Wang, X.-F., Chang, J., Yang, M.-W., Zhong, H.-H., Hong, F.-F., & Yang, S.-L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.122 · Cited by 216 · see citing works
mTORC1 phosphorylates the ULK1-mAtg13-FIP200 autophagy regulatory complex
Chan, E. Y. (2009) · Science Signaling · doi:10.1126/scisignal.284pe51 · Cited by 214 · see citing works
Zhang, Y., Lee, T.-S., Kolb, E. M., Sun, K., Lu, X., Sladek, F. M., Kassab, G. S., Garland, T., & Shyy, J. Y.-J. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000221230.08596.98 · Cited by 212 · cited 1× · see citing works
“AICAR, atheroprotective flow, and statins on ECs can be found through AMPK activation [245,250,251].”
BackgroundAgonist-modulated Regulation of AMP-activated Protein Kinase (AMPK) in Endothelial Cells
Levine, Y. C., Li, G. K., & Michel, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702182200 · Cited by 207 · see citing works
Schwartz, S. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119472 · Cited by 206 · see citing works
Lamounier-Zepter, V., Look, C., Alvarez, J., Christ, T., Ravens, U., Schunck, W.-H., Ehrhart-Bornstein, M., Bornstein, S. R., & Morano, I. (2009) · Circulation Research · doi:10.1161/circresaha.109.200501 · Cited by 203 · see citing works
Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics
DEZFULIAN, C., RAAT, N., SHIVA, S., & GLADWIN, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.001 · Cited by 198 · see citing works
The Mitochondrial Calcium Uniporter Controls Skeletal Muscle Trophism In Vivo
Mammucari, C., Gherardi, G., Zamparo, I., Raffaello, A., Boncompagni, S., Chemello, F., Cagnin, S., Braga, A., Zanin, S., Pallafacchina, G., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.056 · Cited by 190 · see citing works
Garcia-Roves, P. M., Osler, M. E., Holmström, M. H., & Zierath, J. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805078200 · Cited by 190 · see citing works
Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells
Willows, R., Sanders, M. J., Xiao, B., Patel, B. R., Martin, S. R., Read, J., Wilson, J. R., Hubbard, J., Gamblin, S. J., & Carling, D. (2017) · Biochemical Journal · doi:10.1042/bcj20170458 · Cited by 190 · see citing works
Zou, M., Hou, X., Shi, C., Nagata, D., Walsh, K., & Cohen, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204512200 · Cited by 189 · see citing works
Self-citationChronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis
Kumar, D., Branch, B. G., Pattillo, C. B., Hood, J., Thoma, S., Simpson, S., Illum, S., Arora, N., Chidlow, J. H., Langston, W., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711480105 · Cited by 187 · see citing works
AMP-activated protein kinase: Also regulated by ADP?
Hardie, D. G., Carling, D., & Gamblin, S. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.06.004 · Cited by 187 · see citing works
Li, J., Wang, Y., Wang, Y., Wen, X., Ma, X., Chen, W., Huang, F., Kou, J., Qi, L., Liu, B., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.07.010 · Cited by 182 · see citing works
Wang, Q., Liang, B., Shirwany, N. A., & Zou, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017234 · Cited by 181 · see citing works
Self-citationMCU encodes the pore conducting mitochondrial calcium currents
Chaudhuri, D., Sancak, Y., Mootha, V. K., & Clapham, D. E. (2013) · eLife · doi:10.7554/elife.00704 · Cited by 181 · see citing works
Mitochondrial calcium uptake in organ physiology: from molecular mechanism to animal models
Mammucari, C., Raffaello, A., Reane, D. V., Gherardi, G., Mario, A. D., & Rizzuto, R. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2123-2 · Cited by 179 · see citing works
Xie, Z., Dong, Y., Zhang, M., Cui, M.-Z., Cohen, R. A., Riek, U., Neumann, D., Schlattner, U., & Zou, M.-H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511178200 · Cited by 172 · see citing works
Self-citationDifferential regulation by AMP and ADP of AMPK complexes containing different γ subunit isoforms
Ross, F. A., Jensen, T. E., & Hardie, D. G. (2016) · Biochemical Journal · doi:10.1042/bj20150910 · Cited by 172 · see citing works
Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo
Wu, Y., Song, P., Zhang, W., Liu, J., Dai, X., Liu, Z., Lu, Q., Ouyang, C., Xie, Z., Zhao, Z., et al. (2015) · Nature Medicine · doi:10.1038/nm.3826 · Cited by 169 · see citing works
Melatonin attenuates traumatic brain injury‐induced inflammation: a possible role for mitophagy
Lin, C., Chao, H., Li, Z., Xu, X., Liu, Y., Hou, L.-J., Liu, N., & Ji, J. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12337 · Cited by 169 · see citing works
Ducommun, S., Deak, M., Sumpton, D., Ford, R. J., Núñez Galindo, A., Kussmann, M., Viollet, B., Steinberg, G. R., Foretz, M., Dayon, L., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.008 · Cited by 167 · see citing works
Wang, Y., Huang, Y., Lam, K. S. L., Li, Y., Wong, W. T., Ye, H., Lau, C., Vanhoutte, P. M., & Xu, A. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp078 · Cited by 165 · see citing works
Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction
Ikeda, Y., Sato, K., Pimentel, D. R., Sam, F., Shaw, R. J., Dyck, J. R. B., & Walsh, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057273 · Cited by 164 · see citing works
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
Inokuchi‐Shimizu, S., Park, E. J., Roh, Y. S., Yang, L., Zhang, B., Song, J., Liang, S., Pimienta, M., Taniguchi, K., Wu, X., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74068 · Cited by 164 · see citing works
Ma, H., Wang, J., Thomas, D. P., Tong, C., Leng, L., Wang, W., Merk, M., Zierow, S., Bernhagen, J., Ren, J., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.953208 · Cited by 164 · see citing works
ROS-induced ROS release in vascular biology: redox-redox signaling
Zinkevich, N. S., & Gutterman, D. D. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01271.2010 · Cited by 163 · see citing works
Chaube, B., Malvi, P., Singh, S. V., Mohammad, N., Viollet, B., & Bhat, M. K. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.63 · Cited by 162 · see citing works
Localization and Processing of the Amyloid-β Protein Precursor in Mitochondria-Associated Membranes
Prete, D. D., Suski, J. M., Oulès, B., Debayle, D., Gay, A.-S., Lacas‐Gervais, S., Bussiere, R., Bauer, C., Pinton, P., Paterlini-Bréchot, P., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160953 · Cited by 161 · see citing works
Wu, S., Wu, Y., Wu, T.-P., & Wei, Y. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.034 · Cited by 159 · see citing works
Self-citationSelective superoxide generation within mitochondria by the targeted redox cycler MitoParaquat
Robb, E. L., Gawel, J. M., Aksentijević, D., Cochemé, H. M., Stewart, T. S., Shchepinova, M. M., He, Q., Prime, T. A., Bright, T. P., James, A. M., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.021 · Cited by 152 · see citing works
Caballero, A. E., Delgado, A., Aguilar-Salinas, C. A., Herrera, A. N., Castillo, J. L., Cabrera, T., Gomez-Perez, F. J., & Rull, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0019 · Cited by 151 · see citing works
Dauber, I. M., VanBenthuysen, K. M., McMurtry, I. F., Wheeler, G. S., Lesnefsky, E. J., Horwitz, L. D., & Weil, J. V. (1990) · Circulation Research · doi:10.1161/01.res.66.4.986 · Cited by 149 · see citing works
AMPK-mediated activation of MCU stimulates mitochondrial Ca2+ entry to promote mitotic progression
Zhao, H., Li, T., Wang, K., Zhao, F. L., Chen, J., Xu, G., Zhao, J., Li, T., Chen, L., Li, L., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0296-3 · Cited by 149 · see citing works
Żmijewski, J. W., Moellering, D. R., Goffe, C. L., Landar, A. L., Ramachandran, A., & Darley-Usmar, V. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00015.2005 · Cited by 148 · see citing works
The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: An update
Zhang, H., Dellsperger, K. C., & Zhang, C. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-011-0237-1 · Cited by 144 · see citing works
Wang, Q., Zhang, M., Liang, B., Shirwany, N. A., Zhu, Y., & Zou, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025436 · Cited by 144 · see citing works
Self-citationRegulation of mitochondrial processes by protein S-nitrosylation
Piantadosi, C. A. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.03.008 · Cited by 144 · see citing works
AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction
Turdi, S., Fan, X., Li, J., Zhao, J., Huff, A. F., Du, M., & Ren, J. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00586.x · Cited by 141 · see citing works
Lindholm, C. R., Ertel, R. L., Bauwens, J. D., Schmuck, E. G., Mulligan, J. D., & Saupe, K. W. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0199-2 · Cited by 136 · see citing works
Oxidative stress activates AMPK in cultured cells primarily by increasing cellular AMP and/or ADP
Auciello, F. R., Ross, F. A., Ikematsu, N., & Hardie, D. G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.07.025 · Cited by 135 · see citing works
The AMPK-PPARGC1A pathway is required for antimicrobial host defense through activation of autophagy
Yang, C.-S., Kim, J.-J., Lee, H.-M., Jin, H. S., Lee, S.-H., Park, J.-H., Kim, S. J., Kim, J.-M., Han, Y.-M., Lee, M.-S., et al. (2014) · Autophagy · doi:10.4161/auto.28072 · Cited by 131 · see citing works
Flagged first, then by citations
3 of the 278 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Molecular mechanisms of aging and anti-aging strategies
Li, Y., Tian, X., Luo, J., Bao, T., Wang, S., & Wu, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01663-1 · Cited by 301 · see citing works
The role of AMPK in macrophage metabolism, function and polarisation
Cui, Y., Chen, J., Zhang, Z., Shi, H., Sun, W., & Yi, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04772-6 · Cited by 202 · see citing works
Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease
Yan, Q., Liu, S., Sun, Y., Chen, C., Yang, S., Lin, M., Long, J., Yao, J., Lin, Y.-T., Yi, F., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04361-7 · Cited by 183 · see citing works
Yue, D., Zhang, Q., Zhang, J., Liu, W., Chen, L., Wang, M., Li, R., Qin, S., Song, X., & Ji, Y. (2022) · Environment International · doi:10.1016/j.envint.2022.107706 · Cited by 146 · see citing works
The role of aldehyde dehydrogenase 2 in cardiovascular disease
Zhang, J., Guo, Y., Zhao, X., Pang, J., Pan, C., Wang, J., Wei, S., Yu, X., Zhang, C., Chen, Y., et al. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00839-5 · Cited by 142 · see citing works
New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death
Bu, L.-L., Yuan, H., Xie, L., Guo, M.-H., Liao, D., & Zheng, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015160 · Cited by 129 · see citing works
Mitochondria Related Cell Death Modalities and Disease
Tian, C., Liu, Y., Li, Z., Zhu, P., & Zhao, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.832356 · Cited by 113 · see citing works
Li, H., Yang, D., Zhang, Y., Zheng, F., Gao, F., Sun, J., & Shi, G. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00616-5 · Cited by 110 · see citing works
Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy
Meng, Y., Qiu, L., Zeng, X., Hu, X., Zhang, Y., Wan, X., Mao, X., Wu, J., Xu, Y., Xiong, Q., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01253-y · Cited by 113 · see citing works
Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets
Luan, Y., Zhu, X., Jiao, Y., Liu, H., Huang, Z., Pei, J., Xu, Y., Yang, Y., & Ren, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01792-5 · Cited by 106 · see citing works
Targeting AMPK by Statins: A Potential Therapeutic Approach
Dehnavi, S., Kiani, A., Sadeghi, M., Biregani, A. F., Banach, M., Atkin, S. L., Jamialahmadi, T., & Sahebkar, A. (2021) · Drugs · doi:10.1007/s40265-021-01510-4 · Cited by 106 · see citing works
Goel, S. K., Singh, R. P., Singh, V., Singh, H., Kumari, P., Chopra, H., Sharma, R., Nepovimová, E., Vališ, M., Kuča, K., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1022739 · Cited by 112 · see citing works
IL-25 Induced ROS-Mediated M2 Macrophage Polarization via AMPK-Associated Mitophagy
Tsai, M.-L., Tsai, Y., Lin, Y., Hsu, Y., Chen, Y., Tsai, M.-K., Liao, W., Lin, Y.-C., & Hung, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010003 · Cited by 96 · see citing works
Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis
Salnikova, D. I., Orekhova, V. A., Grechko, A. V., Starodubova, A. V., Bezsonov, E. E., Попкова, Т. В., & Orekhov, A. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168990 · Cited by 84 · see citing works
Yin, K., Lu, H., Zhang, Y., Hou, L., Meng, X., Li, J., Zhao, H., & Xing, M. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110180 · Cited by 85 · see citing works
Yan, Y., Li, M., Lin, J., Ji, Y., Wang, K., Yan, D., Shen, Y., Wang, W., Huang, Z., Jiang, H., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.947387 · Cited by 81 · see citing works
Matar, D. B., Zhra, M., Nassar, W. K., Altemyatt, H., Naureen, A., Abotouk, N., Elahi, M. A., & Aljada, A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1592683 · Cited by 80 · see citing works
Palabıyık, A. A., & Palabıyık, E. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10368-8 · Cited by 68 · see citing works
Youssef, M. E., El-Fattah, E. E. A., Abdelhamid, A. M., Eissa, H., El-Ahwany, E. G., Amin, N. A., Hetta, . F., Mahmoud, M. H., Batiha, G. E., Gobba, N. A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.719984 · Cited by 62 · see citing works
Cai, W., Cheng, J., Zong, S.-Y., Yu, Y., Wang, Y., Song, Y., He, R., Yuan, S., Chen, T., Hu, M., et al. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.10.007 · Cited by 60 · see citing works
Cao, S., Xiao, H., Li, X., Zhu, J., Gao, J., Wang, L., & Hu, C. (2021) · Antioxidants · doi:10.3390/antiox10122010 · Cited by 59 · see citing works
Autophagy in sarcopenia: Possible mechanisms and novel therapies
Xie, G., Jin, H., Mikhail, H., Pavel, V., Yang, G., Ji, B., Lu, B., & Li, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115147 · Cited by 57 · see citing works
Proteome characterisation of extracellular vesicles isolated from heart
Claridge, B., Rai, A., Fang, H., Matsumoto, A., Luo, J., McMullen, J. R., & Greening, D. W. (2021) · PROTEOMICS · doi:10.1002/pmic.202100026 · Cited by 54 · see citing works
Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target
Reiss, A. B., Ahmed, S., Johnson, M., Saeedullah, U., & Leon, J. D. (2023) · Metabolites · doi:10.3390/metabo13040479 · Cited by 52 · see citing works
Common methods in mitochondrial research (Review)
Yin, Y., & Shen, H. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5182 · Cited by 52 · see citing works
Zhuo, C., Xin, J., Huang, W., Zhang, D., Yan, X., Li, R., Li, H., Lan, J., Lin, L., Li, L., et al. (2023) · Toxicology · doi:10.1016/j.tox.2023.153597 · Cited by 45 · see citing works
Self-citationHan, H., Li, X., Guo, Y., Zheng, M., Xue, T., & Wang, L. (2021) · Food & Function · doi:10.1039/d0fo02623a · Cited by 44 · see citing works
Humanin and Its Pathophysiological Roles in Aging: A Systematic Review
Coradduzza, D., Congiargiu, A., Chen, Z., Cruciani, S., Zinellu, A., Carru, C., & Medici, S. (2023) · Biology · doi:10.3390/biology12040558 · Cited by 46 · see citing works
Guo, K., & Lü, Y. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1388759 · Cited by 43 · see citing works
Stimulation of AMPK Prevents Diabetes‐Induced Photoreceptor Cell Degeneration
Song, S., Bao, S., Zhang, C., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5587340 · Cited by 42 · see citing works
Zhang, Y., Liu, S., Cao, D., Zhao, M., Lu, H., & Wang, P. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119285 · Cited by 46 · see citing works
Paskeh, M. D. A., Asadi, A., Mirzaei, S., Hashemi, M., Entezari, M., Raesi, R., Hushmandi, K., Zarrabi, A., Ertaş, Y. N., Aref, A. R., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110323 · Cited by 42 · see citing works
Tero-Vescan, A., Degens, H., Matsakas, A., Ștefănescu, R., Ősz, B. E., & Slevin, M. (2025) · Pharmaceuticals · doi:10.3390/ph18081222 · Cited by 44 · see citing works
“For example, AMPK activators such as metformin and berberine improve mitochondrial efficiency and energy substrate utilization, which can reduce fatigue and increase endurance capacity [106,107].”
Mitochondrial dysfunction in oocytes: implications for fertility and ageing
Wang, T., Xu, P., Yuan, J., Chen, H., Guo, X., Gao, J., Wang, Y., Yao, D., Li, X., Liu, B., et al. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01764-6 · Cited by 47 · see citing works
Metabolic syndrome: molecular mechanisms and therapeutic interventions
Zheng, L., Zeng, A., Liu, L., Tian, W., Wang, R., Zhang, L., Hua, H., & Zhao, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00303-5 · Cited by 44 · see citing works
Why is endothelial resilience key to maintain cardiac health?
Tombor, L. S., & Dimmeler, S. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00941-8 · Cited by 37 · see citing works
Visitchanakun, P., Kaewduangduen, W., Charoensappakit, A., Susantitaphong, P., Pisitkun, P., Ritprajak, P., Townamchai, N., & Leelahavanichkul, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111450 · Cited by 38 · see citing works
AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling
Zhao, Q., Song, P., & Zou, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.691585 · Cited by 36 · see citing works
Self-citationZhong, P., Peng, J., Hu, Y., Zhang, J., & Shen, C. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17551 · Cited by 34 · see citing works
Li, X., Chen, W., Jia, Z., Xiao, Y., Shi, A., & Ma, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094256 · Cited by 36 · see citing works
Isop, L. M., Neculau, A. E., Necula, R. D., Kakucs, C., Moga, M., & Dima, L. (2023) · Pharmaceuticals · doi:10.3390/ph16121714 · Cited by 33 · see citing works
Exercise training attenuates angiotensin II-induced cardiac fibrosis by reducing POU2F1 expression
Feng, N., Yu, H., Wang, Y., Zhang, Y., Han, X., & Gao, W. D. (2022) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2022.10.004 · Cited by 33 · see citing works
Exploring Stressors: Impact on Cellular Organelles and Implications for Cellular Functions
Zayani, Z., Matinahmadi, A., Tavakolpournegari, A., & Bidooki, S. H. (2025) · Stresses · doi:10.3390/stresses5020026 · Cited by 34 · see citing works
Guo, Z., Chen, X., Huang, Z., et al. (2022) · Food & Function · doi:10.1039/d1fo03391c · Cited by 32 · see citing works
Exercise-driven cellular autophagy: A bridge to systematic wellness
Zhou, X.-H., Luo, Y., & Yao, X. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.12.036 · Cited by 33 · see citing works
Liang, Y., Chu, P. H., Tian, L., Ho, K., Ip, M., & Mak, J. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.118720 · Cited by 31 · see citing works
Wu, Q., Li, D., Huang, C., Zhang, G., Wang, Z., Liu, J., Yu, H., Song, B., Zhang, N., Li, B., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113517 · Cited by 31 · see citing works
SGLT2 inhibitors and AMPK: The road to cellular housekeeping?
Safaie, N., Masoumi, S., Alizadeh, S., Mirzajanzadeh, P., Nejabati, H., Hajiabbasi, M., Alivirdiloo, V., Basmenji, N. C., Radvar, A. D., Majidi, Z., et al. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3922 · Cited by 33 · see citing works
Targeting mitochondrial dynamics and redox regulation in cardiovascular diseases
Beg, M. A., Huang, M., Vick, L., Rao, K. N. S., Zhang, J., & Chen, Y. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.02.001 · Cited by 30 · see citing works
Luan, P., Zhang, H., Chen, X., Zhu, Y., Hu, G., Cai, J., & Zhang, Z. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113276 · Cited by 30 · see citing works
Zhu, J., Chen, H., Guo, J., Zha, C., & Lu, D. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s386470 · Cited by 30 · see citing works
Laurindo, L. F., Rodrigues, V. D., Laurindo, L. F., Cherain, L. M. A., de Lima, E. P., Boaro, B. L., Oliveira, J. D. S. C., Chagas, E. F. B., Catharin, V. C. S., Haber, J. F. D. S., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123230 · Cited by 31 · see citing works
Chaanine, A. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910579 · Cited by 29 · see citing works
Afzal, O., Altamimi, A. S. A., Mubeen, B., Alzarea, S. I., Almalki, W. H., Al-Qahtani, S. D., Atiya, E. M., Al-Abbasi, F. A., Ali, F., Ullah, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012470 · Cited by 30 · see citing works
Tang, J. Y., Chen, Y., Li, J., Yan, S., Wang, Z., Deng, X., Feng, K., Zhang, Y., Chen, C., Geng, H., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14198 · Cited by 29 · see citing works
Yu, H., Hong, X., Liu, L., Wu, Y., Xie, X., Fang, G., & Zhi, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.754005 · Cited by 33 · see citing works
Adiponectin receptor agonist AdipoRon modulates human and mouse platelet function
Zhou, X., Cheng, Z., Meng, L. M., Lin, W.-Y., Luo, L., Ming, Z., & Hu, Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00943-1 · Cited by 27 · see citing works
Gu, Y., Bai, J., Zhang, J., Zhao, Y., Pan, R., Dong, Y., Cui, H., & Xiao, X. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111285 · Cited by 28 · see citing works
From Kinases to Diseases: Investigating the Role of AMPK in Human Pathologies
Rey, V., & Tamargo‐Gómez, I. (2023) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases1030012 · Cited by 27 · see citing works
Wang, Y., Li, X., Xu, X., Qu, X., & Yang, Y. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001301 · Cited by 27 · see citing works
Zhou, Z., Zhao, Q., Huang, Y., Meng, S., Chen, X., Zhang, G., Chi, Y., Xu, D., Yin, Z., Jiang, H., et al. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18407 · Cited by 24 · see citing works
Zhang, Y., Jiang, X., Wang, W., Lei, L., Sheng, R., Li, S., Luo, J., Liu, H., Zhang, J., Han, X., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321076 · Cited by 25 · see citing works
Xiong, J., Dong, X., Li, S., Jiang, F., Chen, J., Yu, S., Dong, B., & Su, Q. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.657378 · Cited by 25 · see citing works
The Hormetic Effect of Metformin: “Less Is More”?
Panfoli, I., Puddu, A., Bertola, N., Ravera, S., & Maggi, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126297 · Cited by 27 · see citing works
Melnik, B. C., & Schmitz, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911503 · Cited by 27 · see citing works
Liu, D., Ding, J., Li, Z., & Lu, Y. (2023) · Cell Biology International · doi:10.1002/cbin.12090 · Cited by 26 · see citing works
Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy
Zeng, Y., Li, Y., Jiang, W., & Hou, N. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1375400 · Cited by 26 · see citing works
Singh, S. K., Yadav, P., Patel, D., Tanwar, S. S., Sherawat, A., Khurana, A., Bhatti, J. S., & Navik, U. (2024) · Environmental Toxicology · doi:10.1002/tox.24291 · Cited by 25 · see citing works
Liu, Y., Shu, J., Liu, T., Xie, J., Li, T., Li, H., & Li, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175365 · Cited by 25 · see citing works
Liu, C., Guo, X., Zhou, Y., & Wang, H. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s441597 · Cited by 24 · see citing works
Yang, H., Wang, Y., Zhen, S., et al. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023039 · Cited by 22 · see citing works
An update in toxicology of ageing.
Račková, L., Mach, M., & Brnoliaková, Z. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103611 · Cited by 17 · see citing works
Tian, J., Zheng, Y., Mou, T., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-06008-z · Cited by 22 · see citing works
Nrf2/Keap1/ARE regulation by plant secondary metabolites: a new horizon in brain tumor management
Dewanjee, S., Bhattacharya, H., Bhattacharyya, C., Chakraborty, P., Fleishman, J. S., Alexiou, A. T., Papadakis, M., & Jha, S. K. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01878-2 · Cited by 24 · see citing works
Bioactive potential of punicalagin: A comprehensive review
Shabir, I., Dar, A. H., Dash, K. K., Manzoor, S., Srivastava, S., Pandey, V. K., Shams, R., Bashir, I., Khan, S. A., Mukarram, S. A., et al. (2024) · Applied Food Research · doi:10.1016/j.afres.2024.100572 · Cited by 21 · see citing works
Hassanpour, P., Sadeghsoltani, F., Saghebasl, S., Boroumand, S., Khanicheragh, P., Tafti, S. H. A., Rahbarghazi, R., & Rahmati, M. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04193-w · Cited by 22 · see citing works
Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease
Vaez, H., Soraya, H., Garjani, A., & Gholikhani, T. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.004 · Cited by 23 · see citing works
Hu, Y., Gu, X., Zhang, Y., Ma, W., Sun, L., Wang, C., & Ren, B. (2023) · Environmental Toxicology · doi:10.1002/tox.23958 · Cited by 22 · see citing works
Sung, J. Y., Kim, S. G., Park, S., Kim, J., & Choi, H. C. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01297-w · Cited by 23 · see citing works
Deng, Z., Yang, Z., & Peng, J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1992606 · Cited by 21 · see citing works
Epicardial Adipose Tissue as an Independent Cardiometabolic Risk Factor for Coronary Artery Disease
Karampetsou, N., Alexopoulos, L. G., Minia, A., Pliaka, V., Tsolakos, N., Kontzoglou, K., Perrea, D. N., & Patapis, P. (2022) · Cureus · doi:10.7759/cureus.25578 · Cited by 20 · see citing works
Viloria, M. A. D., Li, Q., Lu, W., Nhu, N. T., Liu, Y., Cui, Z.-Y., Cheng, Y., & Lee, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.949744 · Cited by 20 · see citing works
Seksaria, S., Mehan, S., Dutta, B. J., Gupta, G. D., Ganti, S. S., & Singh, A. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23330 · Cited by 23 · see citing works
Isoform-specific roles of AMP-activated protein kinase in cardiac physiology and pathophysiology
Rakoubian, A., Khinchin, J., Yarbro, J. R., Kobayashi, S., & Liang, Q. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1638515 · Cited by 22 · see citing works
Mahmoudi, A. A., Butler, A. E., Jamialahmadi, T., & Sahebkar, A. (2021) · BioMed Research International · doi:10.1155/2021/3654660 · Cited by 20 · see citing works
Yang, L., Chen, X., Chen, D., Yu, B., He, J., Luo, Y., Zheng, P., Chen, H., Yan, H., & Huang, Z. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109327 · Cited by 19 · see citing works
Sexual Dimorphism in Cardiometabolic Diseases: The Role of AMPK
Kvandová, M., Púzserová, A., & Bališ, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511986 · Cited by 19 · see citing works
Exercise Improves Heart Function after Myocardial Infarction: The Merits of AMPK
Zhang, X., Zhao, Y., Guo, D., Luo, M., Zhang, Q., Zhang, L., & Zhang, D. (2024) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-024-07564-2 · Cited by 18 · see citing works
Efentakis, P., Psarakou, G., Varela, A., Papanagnou, E., Chatzistefanou, M., Nikolaou, P., Davos, C. H., Gavriatopoulou, M., Trougakos, I. P., Dimopoulos, M. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010956 · Cited by 18 · see citing works
Shi, B., Liu, S., Huang, A., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/4451779 · Cited by 18 · see citing works
Chen, Z., Zhang, W., Wu, M., Huang, H., Zou, L., & Luo, Q. (2021) · Bioengineered · doi:10.1080/21655979.2021.1993717 · Cited by 18 · see citing works
Kong, L., Liu, Y., Wang, J., Lv, M.-J., Wang, Y.-Z., Sun, W., Cao, H., Guo, R., Zhang, L., Yu, Y., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156529 · Cited by 19 · see citing works
Han, X., Zheng, R., Zhang, J., Liu, Y., Li, Z., Liu, G., Zheng, J., Li, W., Liang, Z.-J., Wang, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61901-z · Cited by 18 · see citing works
Yang, Q., Ma, Q., Xu, J., Liu, Z., Zou, J., Shen, J., Zhou, Y., Da, Q., Mao, X., Lu, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.611354 · Cited by 18 · see citing works
Sun, X. H., Han, Y., Dong, C., Qu, H., Yu, Y., Ju, J., Bai, Y., & Yang, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113162 · Cited by 18 · see citing works
Suksawad, N., Udompornpitak, K., Thawinpipat, N., Korwattanamongkol, P., Visitchanakun, P., Phuengmaung, P., Saisorn, W., Kueanjinda, P., & Leelahavanichkul, A. (2023) · Biomedicines · doi:10.3390/biomedicines11041208 · Cited by 17 · see citing works
Mitochondrial Kinase Signaling for Cardioprotection
Boengler, K., Eickelmann, C., & Kleinbongard, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084491 · Cited by 17 · see citing works
Jiang, S., Huang, C., Wang, S., et al. (2022) · BioMed Research International · doi:10.1155/2022/4293265 · Cited by 16 · see citing works
Deng, X., Luo, H., He, J., et al. (2024) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2024.2332695 · Cited by 16 · see citing works
Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium
Wang, M., Preckel, B., Zuurbier, C. J., & Weber, N. C. (2025) · Basic Research in Cardiology · doi:10.1007/s00395-025-01115-y · Cited by 18 · see citing works
- Authors
- Wu, S., & Zou, M.-H.
- Affiliations
- Georgia State University (US)
- Corresponding author
- Wu, Shengnan
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-07-15
- Volume
- 21
- Issue
- 14
- Pages
- 4987
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7404275
- OpenAlex
- W3043111807
- Cited by
- 286
- References
- 278
- Citations by year
- 2026: 48 · 2025: 71 · 2024: 50 · 2023: 45 · 2022: 43 · 2021: 27 · 2020: 2
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American Heart Association (16POST29960011, 19CDA34760110)
- Georgia Research Alliance
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- AMPK, mitochondrial dysfunction, mitochondrial homeostasis, cardiovascular disease, redox sensing, energy homeostasis, statins, metformin, berberine, polyphenols, resveratrol
- MeSH terms
- Adenosine Triphosphate, Animals, Cardiovascular Diseases, Energy Metabolism, Humans, Mitochondria, Reactive Oxygen Species, AMP-Activated Protein Kinases, Mitochondrial Turnover
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review